[go: up one dir, main page]

WO2012150370A1 - Synergic polyphenol combination - Google Patents

Synergic polyphenol combination Download PDF

Info

Publication number
WO2012150370A1
WO2012150370A1 PCT/ES2012/070302 ES2012070302W WO2012150370A1 WO 2012150370 A1 WO2012150370 A1 WO 2012150370A1 ES 2012070302 W ES2012070302 W ES 2012070302W WO 2012150370 A1 WO2012150370 A1 WO 2012150370A1
Authority
WO
WIPO (PCT)
Prior art keywords
resveratrol
quercetin
catechin
extract
combination according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/ES2012/070302
Other languages
Spanish (es)
French (fr)
Inventor
Jose Angel MARAÑON MAROTO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SELECT BOTANICAL SL
Original Assignee
SELECT BOTANICAL SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SELECT BOTANICAL SL filed Critical SELECT BOTANICAL SL
Publication of WO2012150370A1 publication Critical patent/WO2012150370A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489Sophora, e.g. necklacepod or mamani
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704Polygonum, e.g. knotweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/87Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers

Definitions

  • the present invention relates to polyphenol compositions that have a synergistic antioxidant power.
  • Free radicals are highly reactive molecules that are naturally generated in the tissues, and that can also be formed in an increased way due to environmental stress situations such as, for example, cigarette smoke, the presence of ionizing radiation, ultraviolet radiation, or environmental pollution, as well as other causes such as stress situations or the practice of a very intense exercise. Free radicals are capable of inducing the oxidation of nucleic acids, proteins and lipids of the organism, which can contribute to the acceleration of the aging process and trigger diseases associated with aging such as degenerative diseases, cancer, cardiovascular diseases and dermatological diseases.
  • Resveratrol is a polyphenolic compound present in the seed and in the skin of the grape (Vitis vinifera) and in other plant products. Its therapeutic interest has been reinforced since its possible involvement in the cardioprotective effects of red wine was postulated, as described in the article Siemann et al., Concentration of the phytoalexin resveratrol in wine, Am. J. Eno. Vitic, Free. Rad. Res., 1992, 43, 49-52, and its possible participation in the so-called French paradox: The French population, which has a diet rich in saturated fats, has a lower disease mortality rate cardiovascular than the rest of developed countries. This reduction was associated with the increased consumption of red wine and the presence of resveratrol in red wine.
  • LDL low density lipoproteins
  • the combination with quercetin may contribute to increasing the bioavailability of resveratrol, as described in the article De Santi et al., Sulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoids, Xenobiotica, 2000, 30 (9), 857-866.
  • compositions with resveratrol, catechin, epicatechin and quercetin are described, alone or in combination, for use as cardioprotectors, and their fibrinolytic activity is analyzed in an in vitro model with endothelial cells human derived from the umbilical vein (HUVEC) and in an in vivo model in rat.
  • the examples describe compositions in the form of capsules or orange juice in which resveratrol, quercetin and catechins are combined, in a weight ratio of 1: 2.5: 7.5, equivalent to a 1: 1 molar ratio , 9: 5.9.
  • dietary and cosmetic compositions are described with antioxidant properties comprising a skin extract, seeds and black grape rasp of the species Vitis vinifera containing polyphenols and anthocyanins.
  • polyphenols are catechin, gallic acid, quercetin, and resveratrol. It is described that said combination of polyphenols and anthocyanins has antioxidant properties, in the proportions in which it is obtained directly from the plant extract.
  • resveratrol, quercetin and catechin are in an approximate ratio of 1: 3: 21, equivalent to an approximate molar ratio of 1: 2.3: 16.5 .
  • the object of the invention is a synergistic combination of polyphenols.
  • a composition comprising said combination is also part of the object of the invention.
  • the combination for use as an antioxidant is also part of the invention.
  • the object of the present invention is a synergistic combination of polyphenols comprising resveratrol, quercetin and catechin, with a molar ratio between resveratrol, quercetin and catechin of about 1: 1: 2 or about 1: 1: 5.
  • the authors of this invention have developed a combination of the resveratrol, quercetin and catechin polyphenols in such proportions that, surprisingly, it has a synergistic antioxidant power.
  • the combination of antioxidants comprises resveratrol, quercetin and catechin in a 1: 1: 2 or 1: 1: 5 molar ratio.
  • the molar ratio is 1: 1: 2.
  • the molar ratio is 1: 1: 5.
  • the term “approximately” means, for the value "1" of the molar ratio, a variation between 0.9 and 1.1, preferably between 0.95 and 1.05; for the value "2" a variation between 1, 8 and 2.2, preferably between 1, 9 and 2.1; and for the value "5" a variation between 4.5 and 5.5, preferably between 4.75 and 5.25, and more preferably between 4.9 and 5.1.
  • dry extract means the resulting product after subjecting the plant extract to a drying process whereby substantially all of the water it contains is removed.
  • purified extract means an extract having a polyphenol content equal to or greater than 90% by weight On the dry extract.
  • resveratrol preferably equal to or greater than 95%, more preferably equal to or greater than 98%
  • quercetin preferably equal to or greater than 95% expressed as quercetin dihydrate, more preferably equal to or greater than 98%
  • catechin a catechin content expressed as catechin preferably equal to or greater than 80%, more preferably equal to or greater than 85%.
  • Antioxidants are substances that can protect cells against oxidation and the effects of free radicals, because they eliminate these radicals from the medium and because they inhibit oxidation by oxidizing themselves.
  • antioxidants are polyphenols, which are compounds widely distributed in the plant kingdom, and have an appropriate chemical structure to capture free radicals.
  • polyphenols incorporate more than one phenol group. Its property as an antioxidant comes from its great reactivity as electron donors and the ability of the radical formed to stabilize and delocalize the missing electron.
  • the main sources of polyphenols are red fruits, tea leaves, beer, grapes, wine, olive oil, chocolate, cocoa, nuts, and pomegranates, among others.
  • resveratrol refers to trans-resveratrol and cis-resveratrol interchangeably, and also includes the active ingredient and its possible hydrates and / or solvates.
  • Trans-resveratrol is the common name that designates 5 - [(1 £) -2- (4- hydroxyphenyl) ethenyl] -1,3-benzenediol, which can also be called 3,5,4'-trihydroxystilbene, and that It has the following structure:
  • Cis-resveratrol is the common name that designates 5 - [(1 Z) -2- (4- hydroxyphenyl) ethenyl] -1, 3-benzenediol, and has the double bond of the previous figure in cis position.
  • Trans-resveratrol is a phenolic compound found in nature, produced by various plants. For example, it is one of the constituents of the skin and the grape seed and, consequently, one of the components of wine, especially red wine.
  • Trans-resveratrol was first isolated in 1940 from the root of hellebore, as described in the article MJ Takaoka, Of the phenolic substances of white hellebore (Veratrum grandiflorum Loes, fil), J. Faculty Sci Hokkaido Imperial University, 1949, 3, 1-16.
  • Trans-resveratrol can be obtained as an extract from various plant species such as, for example, skin and grape seed ⁇ Vitis), blueberries (Vaccinium), Polygonum cuspidatum root, hops (Humulus lupulus), Cassia garrettiana , Cassia Quinquangulata, Gnetum klossii, Pterolobium hexapetallum, peanut (Arachis hypogaea), pistachio (Pistacia vera), rhubarb leaves and root (Rheum rhabarbarum and Rheum Rhaponticum), Bauhinia racemosa bark, Veratrum grandiflorum bark Veratrum formosanum root, eucalyptus, spruce and spruce, among others.
  • plant species such as, for example, skin and grape seed ⁇ Vitis), blueberries (Vaccinium), Polygonum cuspidatum root, hops (Humulus lupulus), Cassia garrettian
  • plant extracts with various trans-resveratrol contents can be found, reaching values greater than 95% on the dry extract.
  • Polygonum cuspidatum root extract of the company Select Botanical is a purified extract that has a maximum water content of 8% by weight, and whose dry extract has a trans-resveratrol content greater than 98%, determined by HPLC.
  • resveratrol contents that can be between 0.05% and 98% determined by HPLC.
  • the determination of resveratrol content by HPLC can be done, for example, as described in the article Kolouchová-Hanzl ⁇ ková et al., Rapid method for resveratrol determination by HPLC with electrochemical and UV detections in wines, Food Chem., 2004, 87 ( 1), 151-158.
  • trans-resveratrol can be obtained in substantially pure form through suppliers such as, for example, the Sigma-Aldrich company.
  • Trans-resveratrol can also be synthesized, for example as described in the article Fari ⁇ a et al., An improved synthesis of resveratrol, in Nat. Prod. Res., 2006, 20 (3), 247-52.
  • cis-resveratrol can be obtained, for example, from trans-resveratrol by exposure to ultraviolet radiation.
  • Transrosveratrol is preferably used in the combination of the invention.
  • resveratrol may be of synthetic or natural origin.
  • the source of resveratrol is a plant extract. More preferably as a source of resveratrol, an extract of plant origin with a high trans-resveratrol content is used, preferably greater than 95% on the dried extract, determined by HPLC, more preferably a Polygonum cuspidatum root extract, and even more preferably a purified extract of Polygonum cuspidatum root with a trans-resveratrol content greater than 98% on the dry extract, determined by HPLC. Quercetin
  • Quercetin or 2- (3,4-dihydroxyphenyl) -3,5,7-trihydroxy-4H-1-benzopyran-4- one is a polyphenol that structurally belongs to the flavonoid group and responds to the following formula:
  • Quercetin is widely distributed in nature, and is present in a variety of plants and fruits. Because of this, quercetin can be obtained as an extract, from various vegetables and fruits such as, for example, green tea and black tea (Camellia sinensis), capers, mountain celery (Levisticum officinale), apples, onion, black grape, citrus, papaya, tomato, broccoli, cauliflower, chili (Capsicum annum), blueberries, or Sophora japan, among others.
  • green tea and black tea Camellia sinensis
  • capers mountain celery
  • Amya tomato
  • broccoli cauliflower
  • chili Capsicum annum
  • Sophora japan among others.
  • Quercetin can be found commercially as an extract of plant origin with various contents, which may be greater than 98% on the dry extract, determined by HPLC, expressed as quercetin dihydrate.
  • the purified extract of acacia flowers from Japan or tree of pagodas (Sophora Japónica), from the Select Botanical company is presented in the form of a yellow powder containing quercetin in the form of quercetin dihydrate, with a content of water that is a maximum of 12.5%, and that has a minimum content of quercetin dihydrate of 98% on the dry extract, determined by HPLC, for example as described in the article Beecher et al., Analysis of tea polyphenols , Proc. Soc. Exp. Biol. Med., 1999, 220 (4), 267-70.
  • Quercetin is also found as an onion extract (Allium cepa) with varying concentrations between 0.5% and 40%, and as apple, asparagus and grape extracts.
  • Quercetin can also be obtained commercially in substantially pure form through suppliers such as Sigma-Aldrich.
  • quercetin can be synthesized, for example, as described in the article Shakhova et al., Zh. Obshch Khim., 1962, 32, 390.
  • quercetin is broadly understood and includes the active ingredient and its possible hydrates and / or solvates. In a preferred embodiment of this invention, quercetin is in the form of dihydrate.
  • quercetin may be of synthetic or natural origin.
  • the source of quercetin is a plant extract. More preferably, an extract of plant origin with a high quercetin content is used, such as for example greater than 95% on the dry extract expressed as quercetin dihydrate, and more preferably a japanic Sophora extract, and even more preferably a purified extract of Japan sophora with a content greater than 98% quercetin dihydrate on the dry extract.
  • Catechin is the common name by which it knows the product (2R, 3S) -2- (3,4-dihydroxyphenyl) -3,4-dihydro-2 / - / - chromen-3,5,7-triol, a polyphenol also belonging to the flavonoid group, and which has the following structure:
  • the catechin molecule has two asymmetric carbons or chiral centers in positions 2 and 3, as indicated in the previous structure and, therefore, there are actually four different stereoisomers: two of them in the cis configuration and two in the configuration trans.
  • the two trans forms correspond to the enantiomer (2R, 3S), represented in the above formula, and to the enantiomer (2S, 3R), in which the configuration of the two asymmetric carbons 2 and 3 is reversed.
  • epicatechin corresponds to the product (2R, 3R) -2- (3,4-dihydroxyphenyl) -3,4-dihydro-2H-chromen-3,5,7-triol, which has the following structure:
  • epicatechin is understood as the set formed by the two cis isomers, both the enantiomer (2R, 3R) represented above, and the corresponding enantiomer (2S, 3S), in which the configuration of the two asymmetric carbons 2 and 3.
  • Catechins are also found in nature in the form of dimers and trimers, which are known by the name of proanthocyanidins or procyanidins or oligomeric proanthocyanidins.
  • any of the 4 stereoisomers mentioned that is, both the catechin and the epicatechin and their respective enantiomers
  • catechin any of its possible dimers or trimers in the form of type B proanthocyanidins (dimers formed from catechin and / or epicatechin) or proanthocyanidins type C (trimer formed from epicatechin), dimer in the form of gallate, and any mixture of the above.
  • the source of catechin can be a plant extract with different contents in catechins, which can be equal to or greater than 90% on the dry extract expressed as catechin.
  • the purified extract of Vitis vinifera from the company Select Botanical which is presented in the form of an orange powder with a water content of at most 8% and with a catechin content of approximately 90% on the dry extract expressed as catechin, determined by spectrophotometry, for example as described in the article Peri et al., An Assay of Different Phenolic Fractions in Wines, Am. J. Enol. Vitic., 1971, 22 (2), 55-58.
  • Said extract contains a mixture of trans-catechin, epicatechin, dimer in the form of gallate, and proanthocyanidins.
  • Other sources of catechins are extracts from green tea, cocoa, green coffee and blueberries.
  • catechin (2S, 3R) -2- (3,4-dihydroxyphenyl) -3,4-dihydro-2H-chromen-3,5,7-triol is used in substantially pure form.
  • the catechin is the trans isomer, in any of its enantiomeric (2S, 3R) or (2R, 3S) forms, or a mixture of the two in any proportion, and optionally further containing epicatechin in any of its two enantiomeric forms and / or proanthocyanidins, or any mixture of the above in any proportion, preferably obtained from plant extracts.
  • the source of catechin is a grape extract, that is, an extract of Vitis vinifera preferably with a catechin content equal to or greater than 80% on the dry extract expressed as catechin, and even more preferably employs a purified extract of Vitis vinifera with a catechin content equal to or greater than 90% on the dry extract expressed as catechin.
  • plant extracts can be used as sources of antioxidants containing different resveratrol, quercetin, catechin, or extracts containing mixtures of two or more of these polyphenols.
  • a plant extract containing substantially pure resveratrol is used, that is, with a resveratrol content greater than 90% over the dry extract, preferably greater than 92%, more preferably greater than 95%, and even more preferably greater than 98% .
  • a plant extract containing substantially pure quercetin is used, that is, with a content greater than 90% on the dry extract, preferably greater than 92%, more preferably greater than 95%, and even more preferably greater than 98% expressed as Quercetin dihydrate
  • a plant extract containing substantially pure catechin is used, that is, with a catechin content greater than 80% over the dry extract, preferably greater than 85%, and more preferably greater than 90% expressed as catechin.
  • the combination of antioxidants comprises resveratrol, quercetin and catechin in a molar ratio resveratrol: quercetin: catechin of approximately 1: 1: 2,
  • the source of resveratrol is a root extract of Polygonum cuspidatum, preferably with a content of trans-resveratrol greater than 95% on the dry extract
  • the source of quercetin is an extract of Sophora japan, preferably with a content of quercetin dihydrate greater than 98% on the dry extract
  • the source of catechin is an extract of Vitis vinifera, preferably with a catechin content equal to or greater than 90% on the dry extract expressed as catechin.
  • the combination of antioxidants comprises resveratrol, quercetin and catechin in a molar ratio resveratrol: quercetin: catechin of approximately 1: 1: 5,
  • the source of resveratrol is a root extract of Polygonum cuspidatum, preferably with a content of trans-resveratrol greater than 95% on the dry extract
  • the source of quercetin is an extract of Sophora japan, preferably with a content of quercetin dihydrate greater than 98% on the dry extract
  • the source of catechin is an extract of Vitis vinifera, preferably with a catechin content equal to or greater than 90% on the dry extract expressed as catechin.
  • the combination of antioxidants consists essentially of resveratrol, quercetin and catechin in a molar ratio resveratrol: quercetin: catechin of approximately 1: 1: 2,
  • the source of resveratrol is a root extract of Polygonum cuspidatum, preferably with a content of trans-resveratrol greater than 95% on the dry extract
  • the source of quercetin is an extract of Sophora japan, preferably with a content of quercetin dihydrate greater than 98% on the dry extract
  • the source of catechin is a Vitis vin ⁇ fera extract, preferably with a catechin content equal to or greater than 90% on the dry extract, expressed as catechin.
  • the combination of antioxidants consists essentially of resveratrol, quercetin and catechin in a molar ratio resveratrol: quercetin: catechin of approximately 1: 1: 5,
  • the source of resveratrol is a root extract of Polygonum cuspidatum, preferably with a content of trans-resveratrol greater than 95% on the dry extract
  • the source of quercetin is an extract of Sophora japan, preferably with a content of quercetin dihydrate greater than 98% on the dry extract
  • the source of catechin is a Vitis vinifera extract, preferably with a catechin content equal to or greater than 90% on the dry extract expressed as catechin.
  • the antioxidant combination does not contain routine.
  • polyphenols consisting of trans-resveratrol, catechin ((2R, 3S) -2- (3,4-dihydroxyphenyl) -3,4-dihydro-2H-chromen-3,5,7-triol, its enantiomer or mixtures of both), epicatechin ((2R, 3R) -2- (3,4-dihydroxyphenyl) -3,4-dihydro-2H-chromen-3,5,7-triol, its enantiomer, or mixtures of both), Quercetin and rutin in a 1: 1: 1: 1 molar ratio, where each of the polyphenols have a chromatographic purity equal to or greater than 90%, such as those supplied by the Sigma-Aldrich company, is not part of the invention.
  • the antioxidant power of the compositions of the present invention can be determined using an in vitro method designed to assess the free radical scavenging capacity of the tested substances.
  • the method called TOSC (Total Oxidant Scavenging Capacity), which allows the determination of the antioxidant power of compounds at low concentrations.
  • the antioxidant power of a compound can be determined at a specific concentration, and it can be applied to both solutions with pure antioxidants and complex mixtures.
  • the ability of the substance to be tested to inhibit the oxidation of ⁇ -keto-Y-methylthiobutyric acid is determined by the action of free radicals such as, for example, hydroxyl (HO), peroxyl (ROO) or peroxynitrite (ONOO " ).
  • free radicals such as, for example, hydroxyl (HO), peroxyl (ROO) or peroxynitrite (ONOO " ).
  • H 3 CS-CH 2 -CH 2 -CO-COOH ⁇ H 2 C CH 2 + 1/2 (CH 3 -S) + C0 2
  • the TOSC test against peroxyl radicals was performed since they are more stable and have a longer half-life than hydroxyl radicals or peroxynitrite radicals.
  • Peroxyl radicals can be obtained by thermal decomposition and symmetric hydrolysis of the 2,2'-azobis (2-methylpropionamidine) compound (ABAP).
  • the antioxidant power of the tested substances can be measured by the ability to inhibit the formation of ethylene in the presence of peroxyl radicals compared to a control reaction, in which an antioxidant substance is not used as an inhibitor.
  • TOSC values are determined according to the methodology described in the articles Regoli et al., Quantification of total oxidant scavenging capacity of antioxidants for peroxynitrite, peroxyl radicáis, and hydroxyl radicáis, Toxicol. Appl. Pharm., 1999, 156, 96-105 and Regoli et al., Total oxidant scavenging capacity (TOSC) of microsomal and cytosolic fractions from Antarctic, Arctic and Mediterranean scallops: differentiation between three potent oxidants, Aquat. Toxicol., 2000, 49 (1-2), 13-25.
  • TOSC values are quantified by measuring ethylene formation, by comparison of the integrated areas for each tested substance and the control substance, according to the following equation:
  • Control substances without the ability to eliminate free radicals, have a TOSC value of 0%, since they have the same area under the curve as the control.
  • Compounds that completely prevent the formation of ethylene have an area under the curve equal to 0 and, therefore, a TOSC value of 100%.
  • composition comprising the combination of polyphenols of the invention and an acceptable vehicle.
  • the composition is selected from a pharmaceutical composition, a cosmetic composition, a food composition, a dietary supplement, and a veterinary composition, and the vehicle is respectively pharmaceutical, cosmetic, food, dietary, or veterinarily acceptable.
  • compositions suitable for incorporating the combination of polyphenols of the present invention can be formulated for oral, nasal, rectal, parenteral or topical administration.
  • solid and semi-solid pharmaceutical forms such as tablets, creams, hard capsules, soft capsules, dragees, powder presentations are suitable; such as liquid or semi-liquid, such as syrups or any type of aqueous, or non-aqueous solution, suspension or emulsion.
  • compositions are formulated according to the procedures that are known to the expert in pharmaceutical technology, as described, for example, in the book M. E. Aulton, Pharmacy. The science of the design of pharmaceutical forms, second edition, Elsevier, Madrid, 2004. For example, by mixing the antioxidant combination of the invention with at least one pharmaceutically acceptable carrier or excipient and, optionally, with one or more products with therapeutic or dietary functionalities, such as vitamins, minerals, trace elements and other micronutrients.
  • excipients suitable for use in the pharmaceutical compositions object of the present invention are well known to the expert in pharmaceutical technology and are described, for example, in the book R. C. Rowe, P. J. Sheskey and P.J. Weller, Handbook of Pharmaceutical Excipients, fourth edition, Pharmaceutical Press, 2003.
  • excipients and vehicles suitable for use in liquid formulations in the form of solutions, suspensions or emulsions, are, for example, solvents, buffers, viscosity modifiers, density modifiers, surfactants and emulsifiers, flocculating agents, humectants, preservatives, sweeteners and flavorings, and mixtures of the foregoing.
  • excipients and / or vehicles suitable for use in solid pharmaceutical compositions are, for example, fillers, binders, non-stick agents, lubricants, anti-caking agents, materials for the coating of tablets, gelatin for hard and soft capsules, plasticizers, stabilizers, preservatives, dyes, essences, and mixtures thereof.
  • the combination of polyphenols of the invention can also be incorporated into cosmetic compositions for external application, typically for hair or skin care.
  • Cosmetic forms suitable for incorporating the antioxidant combinations of the present invention are, for example, creams, gels, milks, lotions, sprayable emulsions, and solid bars, among others.
  • the cosmetic compositions are formulated according to the procedures that are known to the person skilled in the art, by mixing the combination of polyphenols of the invention with at least one cosmetically acceptable carrier in which it is dissolved, emulsified, dispersed, or it is suspended.
  • the vehicle is selected from water, a water miscible non-aqueous vehicle, such as ethanol or isopropanol, and a water non-water miscible vehicle, such as paraffin oil.
  • the cosmetic compositions may contain at least one additional cosmetic ingredient, which may be chosen, for example, from the group consisting of surfactants and emulsifiers, lipid compounds and emollients, consistency factors and thickeners, stabilizers, hydrotropes, preservatives, essences, colorants, silicone compounds, fats, waxes, lecithins, phospholipids, UV sun protection factors, film-forming agents, self tanners, or tyrosine inhibitors (depigmentation agents), or mixtures of the above.
  • additional cosmetic ingredient which may be chosen, for example, from the group consisting of surfactants and emulsifiers, lipid compounds and emollients, consistency factors and thickeners, stabilizers, hydrotropes, preservatives, essences, colorants, silicone compounds, fats, waxes, lecithins, phospholipids, UV sun protection factors, film-forming agents, self tanners, or tyrosine inhibitors (depigment
  • the combination of polyphenols of the present invention can be incorporated into food products and dietary supplements, for example in the form of nutraceutical products or functional foods or food supplements for sports nutrition.
  • any type of food composition or dietary supplement is suitable for incorporating the combination of polyphenols object of the invention, for example, infusions, coffees, drinks in general such as juices or other Alcoholic or non-alcoholic beverages, pastries or bakery products, jams, energy bars, cereals, flours, dairy products such as cheese, milk, butter, yogurts or cream, chocolate-based products and sweets such as candy, chewing gum or ice cream , oils, margarine, preserves.
  • the food product incorporating the combination of polyphenols of the invention may additionally contain other products with therapeutic or dietary functionalities, preferably, vitamins, minerals, trace elements or other micronutrients, or other plant extracts of polyphenols source.
  • the food product containing the combination of polyphenols of the invention may additionally contain one or more ingredients, which are chosen from among the usual authorized food additives, well known to those skilled in the art, for example of the type dyes, preservatives , condiments and spices, flavor enhancers, thickeners and gelling agents.
  • the combination of polyphenols of the invention can also be incorporated into veterinary compositions intended for animal feed, in particular for the feeding of domestic animals. Such combinations may be incorporated into pet food compositions, such as those described in patent applications EP-A-1514480 and WO-A-2005/1 10037, by methods well known to those skilled in the art. Applications
  • the composition is selected from the group consisting of a pharmaceutical composition, a cosmetic composition, a food composition, a dietary supplement, and a veterinary composition.
  • the combination of polyphenols object of the present invention can be used therapeutically to prevent or decrease the progression of all those pathological conditions that can be treated with antioxidants and / or free radical scavengers, such as cancer, cardiovascular diseases, inflammatory diseases, coronary diseases, diabetes, Alzheimer's disease, multiple sclerosis or dermatological conditions such as psoriasis or the appearance of eczema , among other.
  • pathological conditions such as cancer, cardiovascular diseases, inflammatory diseases, coronary diseases, diabetes, Alzheimer's disease, multiple sclerosis or dermatological conditions such as psoriasis or the appearance of eczema , among other.
  • the combination of the invention is particularly useful for delaying the symptoms of aging, for its ability to protect organs, tissues and cells against the harmful effects of oxidation. It is also appropriate, for example, to treat premature aging of the skin by preventing the breakdown of collagen fibers and, in general, all tissues.
  • the combination of the invention is also particularly suitable for those subjects most likely to generate free radicals in an increased manner in their organism, for example, smokers, people especially exposed to adverse conditions of environmental pollution, ionizing radiation, excessive sun exposure, subject people to stressful situations, or people who practice intense physical exercise.
  • Example 1 Preparation of an antioxidant composition of resveratrol
  • Quercetin and catechin in 1: 1: 2 molar ratio based on resveratrol and quercetin from vegetable extracts and catechin (2S.3R) In a container equipped with a mixer for solid products 253.16 g of purified extract of root of Polygonum cuspidatum with a water content of 8% and a 98% content of resveratrol on the dry extract, equivalent to 1 mol of resveratrol; 386.59 g of purified extract of Sophora japan with a water content of 12.5% and a content of 100% quercetin dihydrate on the dry extract, equivalent to 1 mol of quercetin; and 580.52 g of catechin (2S, 3R) substantially pure (Sigma), equivalent to 2 moles of catechin, and the whole was mixed until complete homogenization.
  • the antioxidant power of the compositions of the present invention was measured by the TOSC method, as described above. Solutions of concentration 1 ⁇ concentra Terms of the substances or mixtures to be tested were used, and distilled water as a control, whose TOSC value is 0%.
  • Resveratrol-quercetin-catechin R + Q + C ex tr (1: 1: 2): 0.5 ml of solution R, 0.5 ml of solution Q and 1 ml of solution C ex tr were taken , and mixed.
  • This solution contained a concentration of 0.25 ⁇ of resveratrol, 0.25 ⁇ of quercetin and 0.5 ⁇ of catechin.
  • the total concentration of polyphenols was 1 ⁇ .
  • This solution contained a concentration of 0.143 ⁇ of resveratrol, 0.143 ⁇ of quercetin and 0.714 ⁇ of catechin.
  • the total concentration of polyphenols was 1 ⁇ .
  • This solution contained a concentration of 0.25 ⁇ of resveratrol, 0.25 ⁇ of quercetin and 0.5 ⁇ of catechin.
  • the total concentration of polyphenols was 1 ⁇ .
  • This solution contained a concentration of 0.143 ⁇ of resveratrol, 0.143 ⁇ of quercetin and 0.714 ⁇ of catechin.
  • the total concentration of polyphenols was 1 ⁇ .
  • Ethylene formation during the TOSC test was monitored by gas chromatography, with HP 5890-series II equipment, HP Chemstation 5890 Software, and calculated by determining the area under the curve, using the SRI PeakSimple ® program . Linear regression was calculated using the GraphPad Prism ® program . The slope of the regression was calculated in the linear margin of the TOSC control curve versus the concentration of the assets tested.
  • TOSC calculated represents the TOSC value that theoretically corresponds to the samples of the different combinations of antioxidants taking into account only an additive effect of each of them.
  • the calculated value is obtained by multiplying the concentration of each of the antioxidants in the sample by the experimental TOSC of each of the individual antioxidants and dividing by the concentration of the antioxidant in the individual sample. For example in the case of sample 5:
  • the “Increment” column corresponds to the difference between the calculated and experimental TOSC value, and allows quantifying the synergistic effect observed in the antioxidant power of the combinations. It can be seen that the combination of resveratrol, quercetin and catechin of the invention, both in the 1: 1: 2 molar ratio, and in the 1: 1: 5 molar ratio, shows a remarkable synergistic effect. Likewise, it can be observed that, although the synergistic effect with pure catechin (2S, 3R) is slightly higher than that of catechin from grape extract, a comparable synergistic effect can be appreciated in both cases, independent of the source of Catechins used.
  • the "Potency” column reflects the number of times the antioxidant power increases with the combinations object of the invention compared to the antioxidant power obtained from the separate addition of the antioxidant powers of resveratrol, quercetin and catechin.
  • Example 4 Preparation of a food supplement for the prevention of skin aging
  • Example 5 Preparation of a food supplement for the improvement of the prevention of age-related macular degeneration
  • Soft gelatin capsules (14/16 oblong) of black color were prepared with the following filling per capsule:
  • Example 7 Preparation of a functional coffee-based food for the prevention of cardiovascular disease
  • Example 8 Preparation of a food supplement based on natural substances as an antioxidant in sports nutrition
  • Soft gelatin soft capsules (20 oblong) of purple color were prepared with the following filling per capsule:
  • Beta-carotene dunaliella (95% retinol) 30.00
  • Example 9 Preparation of a nutritional supplement for the improvement of the appearance of the skin and brightness of the fur in pets (mammals)
  • the molar ratio resveratrol: quercetin: catechin in this preparation is 1: 1: 5.09.
  • Example 10 Preparation of a nutritional supplement to improve the fertility of stallions (mammals)
  • Soft gelatin capsules (22 oblong) of red color were prepared with the following filling per capsule:

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a combination of the polyphenols resveratrol, quercetin and catechin in a molar ratio of approximately 1:1:2 or, alternatively, approximately 1:1:5, which has synergic antioxidant power. This combination of polyphenols is suitable for incorporation into any type of pharmaceutical, cosmetic, foodstuff or veterinary formulation and may be used in the prevention and treatment of pathological or physiological conditions that can be treated with antioxidant and free-radical scavenger substances.

Description

D E S C R I P C I O N  D E S C R I P C I O N

"COMBINACIÓN SINÉRGICA DE POLIFENOLES" Campo de la técnica "SYNERGIC POLYPHENOL COMBINATION" Field of technique

La presente invención se refiere a composiciones de polifenoles que presentan un poder antioxidante sinérgico. Estado de la técnica anterior  The present invention relates to polyphenol compositions that have a synergistic antioxidant power. Prior art

Los compuestos polifenólicos de origen natural, son reconocidos agentes antioxidantes que se ha demostrado son eficaces como captadores de radicales libres. Los radicales libres son moléculas altamente reactivas que se generan de forma natural en los tejidos, y que pueden también formarse de forma incrementada debido a situaciones de estrés ambiental como, por ejemplo, el humo de los cigarros, a la presencia de radiaciones ionizantes, a la radiación ultravioleta, o a la polución ambiental, así como a otras causas tales como situaciones de estrés o la práctica de un ejercicio muy intenso. Los radicales libres son capaces de inducir la oxidación de ácidos nucleicos, proteínas y lípidos del organismo, lo que puede contribuir a la aceleración del proceso de envejecimiento y a desencadenar enfermedades asociadas al envejecimiento como enfermedades degenerativas, cáncer, enfermedades cardiovasculares y patologías de tipo dermatológico.  Polyphenolic compounds of natural origin are recognized antioxidant agents that have been shown to be effective as free radical scavengers. Free radicals are highly reactive molecules that are naturally generated in the tissues, and that can also be formed in an increased way due to environmental stress situations such as, for example, cigarette smoke, the presence of ionizing radiation, ultraviolet radiation, or environmental pollution, as well as other causes such as stress situations or the practice of a very intense exercise. Free radicals are capable of inducing the oxidation of nucleic acids, proteins and lipids of the organism, which can contribute to the acceleration of the aging process and trigger diseases associated with aging such as degenerative diseases, cancer, cardiovascular diseases and dermatological diseases.

En el estado de la técnica se describe que las propiedades antioxidantes de los polifenoles de origen natural pueden tener aplicación en diferentes áreas terapéuticas, y pueden también contribuir a retardar los signos del envejecimiento gracias a su capacidad de reducir la oxidación celular y tisular.  In the state of the art it is described that the antioxidant properties of naturally occurring polyphenols can be applied in different therapeutic areas, and can also contribute to delaying the signs of aging thanks to their ability to reduce cellular and tissue oxidation.

El resveratrol es un compuesto polifenólico presente en la semilla y en la piel de la uva (Vitis vinifera) y en otros productos vegetales. Su interés terapéutico se ha visto reforzado desde que se postuló su posible implicación en los efectos cardioprotectores del vino tinto, tal como se describe en el artículo Siemann et al., Concentration of the phytoalexin resveratrol in wine, Am. J. Eno. Vitic, Free. Rad. Res., 1992, 43, 49-52, y su posible participación en la denominada paradoja francesa: La población francesa, que tiene una dieta rica en grasas saturadas, tiene una menor tasa de mortalidad por enfermedad cardiovascular que el resto de países desarrollados. Esta reducción, se asoció al mayor consumo de vino tinto y a la presencia del resveratrol en el vino tinto. Resveratrol is a polyphenolic compound present in the seed and in the skin of the grape (Vitis vinifera) and in other plant products. Its therapeutic interest has been reinforced since its possible involvement in the cardioprotective effects of red wine was postulated, as described in the article Siemann et al., Concentration of the phytoalexin resveratrol in wine, Am. J. Eno. Vitic, Free. Rad. Res., 1992, 43, 49-52, and its possible participation in the so-called French paradox: The French population, which has a diet rich in saturated fats, has a lower disease mortality rate cardiovascular than the rest of developed countries. This reduction was associated with the increased consumption of red wine and the presence of resveratrol in red wine.

Numerosos estudios, realizados en modelos experimentales y publicados a lo largo de los últimos años corroboran que el resveratrol:  Numerous studies, conducted in experimental models and published over the last few years confirm that resveratrol:

- puede ser eficaz para prevenir o disminuir la progresión de diversas patologías como, por ejemplo, cáncer, diabetes, y enfermedades cardiovasculares,  - it can be effective in preventing or slowing the progression of various pathologies such as cancer, diabetes, and cardiovascular diseases,

- posee propiedades antivirales y antiinflamatorias, mostrándose como una buena alternativa para el tratamiento de la inflamación crónica,  - it has antiviral and anti-inflammatory properties, showing itself as a good alternative for the treatment of chronic inflammation,

- posee propiedades protectoras en diferentes órganos, especialmente en la cardiopatía isquémica asociada al infarto de miocardio, gracias a su capacidad de prevenir la oxidación de las lipoproteínas de baja densidad (LDL, del inglés low density lipoproteins), y  - it has protective properties in different organs, especially in ischemic heart disease associated with myocardial infarction, thanks to its ability to prevent the oxidation of low density lipoproteins (LDL), and

- frena los síntomas del envejecimiento en levaduras y algunos vertebrados sencillos.  - slows the symptoms of aging in yeasts and some simple vertebrates.

También cabe destacar el estudio de Baur et al., Resveratrol improves health and survival of mice on a high-calorie diet, Nature, 2006, 444, 337-342, en el que se demostró que ratas con dieta rica en grasas presentaban mayores patologías y menor supervivencia que otras sometidas a la misma dieta, pero a las que se les administró además resveratrol.  Also noteworthy is the study by Baur et al., Resveratrol improves health and survival of mice on a high-calorie diet, Nature, 2006, 444, 337-342, in which it was shown that rats with a high-fat diet had higher pathologies and less survival than others undergoing the same diet, but those that were also given resveratrol.

Si bien se han observado efectos farmacológicos para el resveratrol incluso a las concentraciones relativamente bajas presentes en las fuentes habituales de la dieta, dada su baja biodisponibilidad (Walle et al., High absorption but very low bioavailability of oral resveratrol in humans, Drug Metab. Disp., 2004, 32(12), 1377-1382), resulta deseable administrar dosis superiores para alcanzar concentraciones plasmáticas y tisulares más elevadas y para potenciar sus efectos terapéuticos. Sin embargo, se desconocen los posibles efectos nocivos de la administración continuada de dosis altas de resveratrol y, en cualquier caso, el coste económico resultaría muy elevado.  Although pharmacological effects have been observed for resveratrol even at the relatively low concentrations present in the usual sources of the diet, given its low bioavailability (Walle et al., High absorption but very low bioavailability of oral resveratrol in humans, Drug Metab. Disp., 2004, 32 (12), 1377-1382), it is desirable to administer higher doses to achieve higher plasma and tissue concentrations and to enhance their therapeutic effects. However, the possible adverse effects of the continued administration of high doses of resveratrol are unknown and, in any case, the economic cost would be very high.

Otros polifenoles de la familia de los flavonoides conocidos por sus propiedades antioxidantes son la quercetina y las catequinas tal como se describe, por ejemplo, en los artículos Zhang et al., Antioxidant properties of quercetin, Adv. Exp. Med. Biol., 201 1 , 915, 283-9, y Plumb et al., Antioxidant properties of catechins and proanthocyanidins: effect of polymerisation, galloylation and glycosylation, 1998, 29 (4), 351 -8. Other polyphenols of the flavonoid family known for their antioxidant properties are quercetin and catechins as described, for example, in articles Zhang et al., Antioxidant properties of quercetin, Adv. Exp. Med. Biol., 201 1, 915, 283-9, and Plumb et al., Antioxidant properties of catechins and proanthocyanidins: effect of polymerisation, galloylation and glycosylation, 1998, 29 (4), 351-8.

En el estado de la técnica se han descrito combinaciones de resveratrol con otros polifenoles para aumentar su biodisponibilidad.  In the state of the art combinations of resveratrol with other polyphenols have been described to increase their bioavailability.

Por ejemplo, la combinación con quercetina, puede contribuir a aumentar la biodisponibilidad del resveratrol, tal como se describe en el artículo De Santi et al., Sulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoids, Xenobiotica, 2000, 30 (9), 857-866.  For example, the combination with quercetin may contribute to increasing the bioavailability of resveratrol, as described in the article De Santi et al., Sulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoids, Xenobiotica, 2000, 30 (9), 857-866.

En el estado de la técnica se han descrito algunas combinaciones de resveratrol con otros polifenoles, en particular con quercetina y catequinas, en diferentes proporciones.  Some combinations of resveratrol with other polyphenols, in particular with quercetin and catechins, in different proportions have been described in the state of the art.

La solicitud de patente internacional WO-A-2010/135589 está dirigida específicamente a suplementos dietéticos bebibles preparados en base a una suspensión de resveratrol en agua a la que, opcionalmente, se añaden otros ingredientes, por ejemplo, quercetina y/o catequinas procedentes de un extracto de té verde, y que están principalmente en forma galato de epigalocatequina, así como otros antioxidantes en forma de extractos o concentrados de origen vegetal, y también otros agentes denominados "energéticos", también de origen vegetal. No se describe ninguna proporción preferida entre el resveratrol y el resto de los componentes adicionales. En particular, se describe un ejemplo concreto de bebida, en la que la proporción en peso entre resveratrol, quercetina y catequinas resultó ser de 17,2:3,4:1 , equivalente a una relación molar de 21 ,8:3,3:1 .  International patent application WO-A-2010/135589 is specifically directed to drinkable dietary supplements prepared based on a suspension of resveratrol in water to which, optionally, other ingredients are added, for example, quercetin and / or catechins from an extract of green tea, and which are mainly in the form of epigallocatechin gallate, as well as other antioxidants in the form of extracts or concentrates of plant origin, and also other agents called "energy", also of plant origin. No preferred ratio between resveratrol and the rest of the additional components is described. In particular, a specific example of a beverage is described, in which the weight ratio between resveratrol, quercetin and catechins was found to be 17.2: 3.4: 1, equivalent to a molar ratio of 21, 8: 3.3 :one .

En la solicitud de patente internacional WO-A-03/015738 se describe una composición cosmética que puede utilizarse para la lucha contra el envejecimiento de la piel y que incluye una combinación de extractos de semillas de uva, de hojas de uva y de pieles de uva. Dichos extractos de semillas de uva contienen polifenoles, especialmente catequinas en cantidades de hasta el 15% en peso, los extractos de hojas de uva contienen quercetinas en cantidades de hasta el 5% en peso, y los extractos de pieles de uva contienen resveratroles en cantidades de hasta el 5% en peso. También se describe un ejemplo con una mezcla de extractos de piel, de hoja y de semillas de uva, que representa una combinación de resveratrol:quercetina:catequinas en una proporción aproximada de 1 :1 :3 en peso, equivalente a una relación molar aproximada de 1 ,3:1 :3,1. Se describe que dicha combinación presenta un efecto sinérgico en cuanto a la inhibición de las metaloproteinasas de matriz (MMP). International patent application WO-A-03/015738 describes a cosmetic composition that can be used for the fight against skin aging and that includes a combination of grape seed extracts, grape leaves and skins. grape. Such grape seed extracts contain polyphenols, especially catechins in amounts up to 15% by weight, grape leaf extracts contain quercetins in amounts up to 5% by weight, and grape skin extracts contain resveratrols in amounts. up to 5% by weight. An example is also described with a mixture of skin, leaf and grape seed extracts, which represents a combination of resveratrol: quercetin: catechins in an approximate ratio of 1: 1: 3 by weight, equivalent to an approximate molar ratio of 1, 3: 1: 3.1. Be describes that said combination has a synergistic effect as regards the inhibition of matrix metalloproteinases (MMP).

En la solicitud de patente internacional WO-A-02/081651 se describen composiciones con resveratrol, catequina, epicatequina y quercetina, solos o en combinación, para su uso como cardioprotectores, y se analiza su actividad fibrinolítica en un modelo in vitro con células endoteliales humanas derivadas de la vena umbilical (HUVEC) y en un modelo in vivo en rata. En los ejemplos se describen composiciones en forma de cápsulas o zumo de naranja en las que se combina resveratrol, quercetina y catequinas, en una proporción en peso de 1 :2,5:7,5, equivalente a una relación molar de 1 :1 ,9:5,9.  In international patent application WO-A-02/081651 compositions with resveratrol, catechin, epicatechin and quercetin are described, alone or in combination, for use as cardioprotectors, and their fibrinolytic activity is analyzed in an in vitro model with endothelial cells human derived from the umbilical vein (HUVEC) and in an in vivo model in rat. The examples describe compositions in the form of capsules or orange juice in which resveratrol, quercetin and catechins are combined, in a weight ratio of 1: 2.5: 7.5, equivalent to a 1: 1 molar ratio , 9: 5.9.

Por otro lado, en la solicitud de patente estadounidense US-A- 2010/0247670 se describe un extracto seco obtenido a partir de uva negra de la variedad Vitis labrusca, que contiene resveratrol, quercetina, catequina y taninos. También se describe la extracción con agua caliente del extracto seco para la obtención de infusiones, que resultaron eficaces para el tratamiento de diversas afecciones, tales como resfriado común, hipercolesterolemia o hiperglucemia, o para tratamientos dermatológicos de tipo cosmético. Se describe también el análisis de dos de las infusiones preparadas, según el cual la proporción en peso entre resveratrol, quercetina y catequina es de 1 :5:15 y 1 :4:63, equivalentes respectivamente a unas relaciones molares de 1 :3,8:1 1 ,8 y 1 :3:49,5.  On the other hand, in US patent application US-A-2010/0247670 a dry extract obtained from black grape of the Vitis labrusca variety is described, which contains resveratrol, quercetin, catechin and tannins. It also describes the extraction with hot water of the dry extract to obtain infusions, which were effective for the treatment of various conditions, such as common cold, hypercholesterolemia or hyperglycemia, or for dermatological treatments of cosmetic type. The analysis of two of the prepared infusions is also described, according to which the weight ratio between resveratrol, quercetin and catechin is 1: 5: 15 and 1: 4: 63, equivalent respectively to molar ratios of 1: 3, 8: 1 1, 8 and 1: 3: 49.5.

Análogamente, en la solicitud de patente española ES-A-2217966 se describen composiciones farmacéuticas, dietéticas y cosméticas con propiedades antioxidantes que comprenden un extracto de piel, semillas y raspa de uva negra de la especie Vitis vinifera que contiene polifenoles y antocianos. Entre los polifenoles se encuentran catequina, ácido gálico, quercetina, y resveratrol. Se describe que dicha combinación de polifenoles y antocianos tiene propiedades antioxidantes, en las proporciones en que se obtiene directamente del extracto vegetal. También se describe el resultado del análisis de un extracto de uva negra, en el que resveratrol, quercetina y catequina están en una proporción aproximada de 1 :3:21 , equivalente a una relación molar aproximada de 1 :2,3:16,5.  Similarly, in the Spanish patent application ES-A-2217966 pharmaceutical, dietary and cosmetic compositions are described with antioxidant properties comprising a skin extract, seeds and black grape rasp of the species Vitis vinifera containing polyphenols and anthocyanins. Among the polyphenols are catechin, gallic acid, quercetin, and resveratrol. It is described that said combination of polyphenols and anthocyanins has antioxidant properties, in the proportions in which it is obtained directly from the plant extract. The result of the analysis of a black grape extract is also described, in which resveratrol, quercetin and catechin are in an approximate ratio of 1: 3: 21, equivalent to an approximate molar ratio of 1: 2.3: 16.5 .

Subsiste, pues, la necesidad de poder disponer de una composición de resveratrol con propiedades antioxidantes mejoradas, que presente un poder antioxidante elevado incluso a dosis relativamente bajas. Objeto de la invención The need therefore remains to be able to have a resveratrol composition with improved antioxidant properties, which has a high antioxidant power even at relatively low doses. Object of the invention

El objeto de la invención es una combinación sinérgica de polifenoles. The object of the invention is a synergistic combination of polyphenols.

También forma parte del objeto de la invención una composición que comprende dicha combinación. A composition comprising said combination is also part of the object of the invention.

Forma parte también de la invención la utilización de la combinación para la preparación de una composición con poder antioxidante.  The use of the combination for the preparation of a composition with antioxidant power is also part of the invention.

También forma parte de la invención la combinación para uso como antioxidante.  The combination for use as an antioxidant is also part of the invention.

Descripción detallada de la invención Detailed description of the invention

El objeto de la presente invención es una combinación sinérgica de polifenoles que comprende resveratrol, quercetina y catequina, con una relación molar entre resveratrol, quercetina y catequina de aproximadamente 1 :1 :2 ó aproximadamente 1 :1 :5.  The object of the present invention is a synergistic combination of polyphenols comprising resveratrol, quercetin and catechin, with a molar ratio between resveratrol, quercetin and catechin of about 1: 1: 2 or about 1: 1: 5.

Los autores de esta invención han desarrollado una combinación de los polifenoles resveratrol, quercetina y catequina en unas proporciones tales que, sorprendentemente, presenta un poder antioxidante sinérgico.  The authors of this invention have developed a combination of the resveratrol, quercetin and catechin polyphenols in such proportions that, surprisingly, it has a synergistic antioxidant power.

En una realización preferida, la combinación de antioxidantes comprende resveratrol, quercetina y catequina en una relación molar 1 :1 :2 ó 1 :1 :5.  In a preferred embodiment, the combination of antioxidants comprises resveratrol, quercetin and catechin in a 1: 1: 2 or 1: 1: 5 molar ratio.

En una realización preferida, la relación molar es 1 :1 :2.  In a preferred embodiment, the molar ratio is 1: 1: 2.

En otra realización preferida, la relación molar es 1 :1 :5.  In another preferred embodiment, the molar ratio is 1: 1: 5.

En el contexto de la invención, por el término "aproximadamente" se entiende, para el valor "1 " de la relación molar, una variación entre 0,9 y 1 ,1 , preferiblemente entre 0,95 y 1 ,05; para el valor "2" una variación entre 1 ,8 y 2,2, preferiblemente entre 1 ,9 y 2,1 ; y para el valor "5" una variación entre 4,5 y 5,5, preferiblemente entre 4,75 y 5,25, y más preferiblemente entre 4,9 y 5,1.  In the context of the invention, the term "approximately" means, for the value "1" of the molar ratio, a variation between 0.9 and 1.1, preferably between 0.95 and 1.05; for the value "2" a variation between 1, 8 and 2.2, preferably between 1, 9 and 2.1; and for the value "5" a variation between 4.5 and 5.5, preferably between 4.75 and 5.25, and more preferably between 4.9 and 5.1.

En toda la descripción los porcentajes se refieren a porcentajes en peso y las relaciones son relaciones molares.  Throughout the description the percentages refer to percentages by weight and the relationships are molar ratios.

En el marco de esta invención, se entiende por "extracto seco" el producto resultante después de someter el extracto vegetal a un proceso de secado por el que se elimina sustancialmente toda el agua que contiene.  Within the framework of this invention, "dry extract" means the resulting product after subjecting the plant extract to a drying process whereby substantially all of the water it contains is removed.

En el marco de esta invención, se entiende por "extracto purificado" un extracto que tiene un contenido de polifenol igual o superior al 90% en peso sobre el extracto seco. En el caso del resveratrol preferiblemente igual o superior al 95%, más preferiblemente igual o superior al 98%; en el caso de la quercetina preferiblemente igual o superior al 95% expresado como dihidrato de quercetina, más preferiblemente igual o superior al 98%; y en el caso de la catequina un contenido en catequinas expresado como catequina preferiblemente igual o superior al 80%, más preferiblemente igual o superior al 85%. In the context of this invention, "purified extract" means an extract having a polyphenol content equal to or greater than 90% by weight On the dry extract. In the case of resveratrol preferably equal to or greater than 95%, more preferably equal to or greater than 98%; in the case of quercetin preferably equal to or greater than 95% expressed as quercetin dihydrate, more preferably equal to or greater than 98%; and in the case of the catechin a catechin content expressed as catechin preferably equal to or greater than 80%, more preferably equal to or greater than 85%.

Antioxidantes Antioxidants

Los antioxidantes son sustancias que pueden proteger las células contra la oxidación y los efectos de los radicales libres, porque eliminan dichos radicales del medio y porque inhiben la oxidación oxidándose ellos mismos.  Antioxidants are substances that can protect cells against oxidation and the effects of free radicals, because they eliminate these radicals from the medium and because they inhibit oxidation by oxidizing themselves.

Entre los antioxidantes se encuentran los polifenoles, que son compuestos ampliamente distribuidos en el reino vegetal, y que poseen una estructura química apropiada para capturar radicales libres.  Among the antioxidants are polyphenols, which are compounds widely distributed in the plant kingdom, and have an appropriate chemical structure to capture free radicals.

En su molécula los polifenoles incorporan más de un grupo fenol. Su propiedad como antioxidante proviene de su gran reactividad como donantes de electrones y de la capacidad del radical formado para estabilizar y deslocalizar el electrón desapareado.  In its molecule, polyphenols incorporate more than one phenol group. Its property as an antioxidant comes from its great reactivity as electron donors and the ability of the radical formed to stabilize and delocalize the missing electron.

Las principales fuentes de polifenoles son los frutos rojos, las hojas de té, cerveza, uva, vino, aceite de oliva, chocolate, cacao, nueces, y granadas, entre otros.  The main sources of polyphenols are red fruits, tea leaves, beer, grapes, wine, olive oil, chocolate, cocoa, nuts, and pomegranates, among others.

Resveratrol Resveratrol

En el contexto de la invención el término resveratrol se refiere a trans- resveratrol y a cis-resveratrol indistintamente, y también incluye al principio activo y a sus posibles hidratos y/o solvatos.  In the context of the invention the term resveratrol refers to trans-resveratrol and cis-resveratrol interchangeably, and also includes the active ingredient and its possible hydrates and / or solvates.

El trans-resveratrol es el nombre común que designa al 5-[(1 £)-2-(4- hidroxifenil)etenil]-1 ,3-bencenodiol, que también puede denominarse 3,5,4'- trihidroxiestilbeno, y que tiene la siguiente estructura:  Trans-resveratrol is the common name that designates 5 - [(1 £) -2- (4- hydroxyphenyl) ethenyl] -1,3-benzenediol, which can also be called 3,5,4'-trihydroxystilbene, and that It has the following structure:

Figure imgf000007_0001
El cis-resveratrol es el nombre común que designa al 5-[(1 Z)-2-(4- hidroxifenil)etenil]-1 ,3-bencenodiol, y tiene el doble enlace de la figura anterior en posición cis.
Figure imgf000007_0001
Cis-resveratrol is the common name that designates 5 - [(1 Z) -2- (4- hydroxyphenyl) ethenyl] -1, 3-benzenediol, and has the double bond of the previous figure in cis position.

El trans-resveratrol es un compuesto fenólico que se encuentra en la naturaleza, producido por diversas plantas. Así por ejemplo, es uno de los constituyentes de la piel y la semilla de uva y, por consiguiente, uno de los componentes del vino, especialmente del vino tinto.  Trans-resveratrol is a phenolic compound found in nature, produced by various plants. For example, it is one of the constituents of the skin and the grape seed and, consequently, one of the components of wine, especially red wine.

El trans-resveratrol fue aislado por primera vez en el año 1940 a partir de la raíz del eléboro, tal como se describe en el artículo M. J. Takaoka, Of the phenolic substances of white hellebore (Veratrum grandiflorum Loes, fil), J. Faculty Sci. Hokkaido Imperial University, 1949, 3, 1 -16.  Trans-resveratrol was first isolated in 1940 from the root of hellebore, as described in the article MJ Takaoka, Of the phenolic substances of white hellebore (Veratrum grandiflorum Loes, fil), J. Faculty Sci Hokkaido Imperial University, 1949, 3, 1-16.

El trans-resveratrol puede obtenerse como extracto a partir diversas especies vegetales como, por ejemplo, la piel y la semilla de uva {Vitis), los arándanos (Vaccinium), la raíz de Polygonum cuspidatum, el lúpulo (Humulus lupulus), Cassia garrettiana, Cassia Quinquangulata, Gnetum klossii, Pterolobium hexapetallum, el cacahuete (Arachis hypogaea), el pistacho (Pistacia vera), hojas y raíz del ruibarbo (Rheum rhabarbarum y Rheum Rhaponticum), la corteza de Bauhinia racemosa, las hojas de Veratrum grandiflorum y la raíz de Veratrum formosanum, el eucalipto, el abeto y la pícea, entre otros.  Trans-resveratrol can be obtained as an extract from various plant species such as, for example, skin and grape seed {Vitis), blueberries (Vaccinium), Polygonum cuspidatum root, hops (Humulus lupulus), Cassia garrettiana , Cassia Quinquangulata, Gnetum klossii, Pterolobium hexapetallum, peanut (Arachis hypogaea), pistachio (Pistacia vera), rhubarb leaves and root (Rheum rhabarbarum and Rheum Rhaponticum), Bauhinia racemosa bark, Veratrum grandiflorum bark Veratrum formosanum root, eucalyptus, spruce and spruce, among others.

Comercialmente se pueden encontrar extractos vegetales con diversos contenidos de trans-resveratrol, llegando a valores superiores al 95% sobre el extracto seco.  Commercially, plant extracts with various trans-resveratrol contents can be found, reaching values greater than 95% on the dry extract.

Por ejemplo, el extracto de raíz Polygonum cuspidatum de la compañía Select Botanical, es un extracto purificado que tiene un contenido de agua como máximo del 8% en peso, y cuyo extracto seco presenta un contenido de trans- resveratrol superior al 98%, determinado por HPLC.  For example, Polygonum cuspidatum root extract of the company Select Botanical, is a purified extract that has a maximum water content of 8% by weight, and whose dry extract has a trans-resveratrol content greater than 98%, determined by HPLC.

Así mismo, existen extractos provenientes de semilla de uva y de raíz de Polygonum cuspidatum generalmente, con contenidos muy variables de resveratrol que pueden estar comprendidos entre el 0,05% y el 98% determinados por HPLC. La determinación del contenido de resveratrol por HPLC puede hacerse, por ejemplo, según se describe en el artículo Kolouchová- Hanzlíková et al., Rapid method for resveratrol determination by HPLC with electrochemical and UV detections in wines, Food Chem., 2004, 87 (1 ), 151-158. Así mismo, el trans-resveratrol puede obtenerse en forma sustancialmente pura a través de suministradores como, por ejemplo, la empresa Sigma-Aldrich. Likewise, there are extracts from grape seed and Polygonum cuspidatum root generally, with very variable resveratrol contents that can be between 0.05% and 98% determined by HPLC. The determination of resveratrol content by HPLC can be done, for example, as described in the article Kolouchová-Hanzlíková et al., Rapid method for resveratrol determination by HPLC with electrochemical and UV detections in wines, Food Chem., 2004, 87 ( 1), 151-158. Likewise, trans-resveratrol can be obtained in substantially pure form through suppliers such as, for example, the Sigma-Aldrich company.

El trans-resveratrol también puede sintetizarse, por ejemplo según se describe en el artículo Fariña et al., An improved synthesis of resveratrol, en Nat. Prod. Res., 2006, 20 (3), 247-52.  Trans-resveratrol can also be synthesized, for example as described in the article Fariña et al., An improved synthesis of resveratrol, in Nat. Prod. Res., 2006, 20 (3), 247-52.

Por su parte, el cis-resveratrol se puede obtener, por ejemplo, a partir de trans-resveratrol por exposición a la radiación ultravioleta.  On the other hand, cis-resveratrol can be obtained, for example, from trans-resveratrol by exposure to ultraviolet radiation.

En la combinación de la invención preferiblemente se emplea trans- resveratrol.  Transrosveratrol is preferably used in the combination of the invention.

En la combinación de la invención el resveratrol puede ser de origen sintético o natural. Cuando es de origen natural, preferiblemente la fuente de resveratrol es un extracto vegetal. Más preferiblemente como fuente de resveratrol se emplea un extracto de origen vegetal con un contenido elevado en trans-resveratrol, preferiblemente superior al 95% sobre el extracto seco, determinado por HPLC, más preferiblemente un extracto de raíz de Polygonum cuspidatum, y aún más preferiblemente un extracto purificado de raíz de Polygonum cuspidatum con un contenido de trans-resveratrol superior al 98% sobre el extracto seco, determinado por HPLC. Quercetina  In the combination of the invention, resveratrol may be of synthetic or natural origin. When it is naturally occurring, preferably the source of resveratrol is a plant extract. More preferably as a source of resveratrol, an extract of plant origin with a high trans-resveratrol content is used, preferably greater than 95% on the dried extract, determined by HPLC, more preferably a Polygonum cuspidatum root extract, and even more preferably a purified extract of Polygonum cuspidatum root with a trans-resveratrol content greater than 98% on the dry extract, determined by HPLC. Quercetin

La quercetina o 2-(3,4-dihidroxifenil)-3,5,7-trihidroxi-4H-1 -benzopiran-4- ona, es un polifenol que estructuralmente pertenece al grupo de los flavonoides y que responde a la siguiente fórmula:  Quercetin or 2- (3,4-dihydroxyphenyl) -3,5,7-trihydroxy-4H-1-benzopyran-4- one, is a polyphenol that structurally belongs to the flavonoid group and responds to the following formula:

Figure imgf000009_0001
Figure imgf000009_0001

La quercetina está ampliamente distribuida en la naturaleza, y está presente en gran variedad de plantas y frutos. Debido a ello, la quercetina puede obtenerse como extracto, a partir de diversos vegetales y frutos tales como, por ejemplo, té verde y té negro (Camellia sinensis), alcaparras, apio de monte (Levisticum officinale), manzanas, cebolla, uva negra, cítricos, papaya, tomate, brócoli, coliflor, chile (Capsicum annum), arándanos, o Sophora japónica, entre otros. Quercetin is widely distributed in nature, and is present in a variety of plants and fruits. Because of this, quercetin can be obtained as an extract, from various vegetables and fruits such as, for example, green tea and black tea (Camellia sinensis), capers, mountain celery (Levisticum officinale), apples, onion, black grape, citrus, papaya, tomato, broccoli, cauliflower, chili (Capsicum annum), blueberries, or Sophora japan, among others.

La quercetina se puede encontrar comercialmente como extracto de origen vegetal con diversos contenidos, que pueden llegar a ser superiores al 98% sobre el extracto seco, determinado por HPLC, expresado como dihidrato de quercetina. Por ejemplo, el extracto purificado de flores de acacia del Japón o árbol de las pagodas (Sophora Japónica), de la compañía Select Botanical, se presenta en forma de un polvo amarillo que contiene quercetina en forma de dihidrato de quercetina, con un contenido en agua que como máximo es del 12,5%, y que tiene un contenido mínimo de dihidrato de quercetina del 98% sobre el extracto seco, determinado por HPLC, por ejemplo según se describe en el artículo Beecher et al., Analysis of tea polyphenols, Proc. Soc. Exp. Biol. Med., 1999, 220(4), 267-70.  Quercetin can be found commercially as an extract of plant origin with various contents, which may be greater than 98% on the dry extract, determined by HPLC, expressed as quercetin dihydrate. For example, the purified extract of acacia flowers from Japan or tree of pagodas (Sophora Japónica), from the Select Botanical company, is presented in the form of a yellow powder containing quercetin in the form of quercetin dihydrate, with a content of water that is a maximum of 12.5%, and that has a minimum content of quercetin dihydrate of 98% on the dry extract, determined by HPLC, for example as described in the article Beecher et al., Analysis of tea polyphenols , Proc. Soc. Exp. Biol. Med., 1999, 220 (4), 267-70.

También se encuentra quercetina como extracto de cebolla (Allium cepa) con concentraciones variables comprendidas entre el 0,5% y el 40%, y como extractos de manzana, espárrago y uvas.  Quercetin is also found as an onion extract (Allium cepa) with varying concentrations between 0.5% and 40%, and as apple, asparagus and grape extracts.

La quercetina también puede obtenerse comercialmente en forma sustancialmente pura a través de suministradores tales como Sigma-Aldrich.  Quercetin can also be obtained commercially in substantially pure form through suppliers such as Sigma-Aldrich.

Por otro lado, la quercetina puede sintetizarse, por ejemplo, según se describe en el artículo Shakhova et al., Zh. Obshch. Khim., 1962, 32, 390.  On the other hand, quercetin can be synthesized, for example, as described in the article Shakhova et al., Zh. Obshch Khim., 1962, 32, 390.

En el contexto de la presente invención, el término quercetina se entiende en forma amplia e incluye al principio activo y a sus posibles hidratos y/o solvatos. En una realización preferida de esta invención, la quercetina está en forma de dihidrato.  In the context of the present invention, the term quercetin is broadly understood and includes the active ingredient and its possible hydrates and / or solvates. In a preferred embodiment of this invention, quercetin is in the form of dihydrate.

En la combinación de la invención la quercetina puede ser de origen sintético o natural. Cuando es de origen natural, preferiblemente la fuente de quercetina es un extracto vegetal. Más preferiblemente se emplea un extracto de origen vegetal con un contenido elevado de quercetina, como por ejemplo superior al 95% sobre el extracto seco expresado como dihidrato de quercetina, y más preferiblemente un extracto de Sophora japónica, y aún más preferiblemente un extracto purificado de Sophora japónica con un contenido superior al 98% de dihidrato de quercetina sobre el extracto seco. Catequina In the combination of the invention, quercetin may be of synthetic or natural origin. When it is naturally occurring, preferably the source of quercetin is a plant extract. More preferably, an extract of plant origin with a high quercetin content is used, such as for example greater than 95% on the dry extract expressed as quercetin dihydrate, and more preferably a japanic Sophora extract, and even more preferably a purified extract of Japan sophora with a content greater than 98% quercetin dihydrate on the dry extract. Catechin

La catequina es el nombre común por el que conoce al producto (2R,3S)-2- (3,4-dihidroxifenil)-3,4-dihidro-2/-/-cromen-3,5,7-triol, un polifenol también perteneciente al grupo de los flavonoides, y que tiene la siguiente estructura:  Catechin is the common name by which it knows the product (2R, 3S) -2- (3,4-dihydroxyphenyl) -3,4-dihydro-2 / - / - chromen-3,5,7-triol, a polyphenol also belonging to the flavonoid group, and which has the following structure:

Figure imgf000011_0001
Figure imgf000011_0001

La molécula de catequina tiene dos carbonos asimétricos o centros quirales en las posiciones 2 y 3, tal como se indica en la estructura anterior y, por tanto, existen en realidad cuatro estereoisómeros distintos: dos de ellos en la configuración cis y dos en la configuración trans. Las dos formas trans corresponden al enantiomero (2R,3S), representado en la fórmula anterior, y al enantiomero (2S,3R), en el que se invierte la configuración de los dos carbonos asimétricos 2 y 3. The catechin molecule has two asymmetric carbons or chiral centers in positions 2 and 3, as indicated in the previous structure and, therefore, there are actually four different stereoisomers: two of them in the cis configuration and two in the configuration trans. The two trans forms correspond to the enantiomer (2R, 3S), represented in the above formula, and to the enantiomer (2S, 3R), in which the configuration of the two asymmetric carbons 2 and 3 is reversed.

Los dos enantiómeros que están en configuración cis se denominan habitualmente epicatequina. Así pues, la denominación epicatequina corresponde al producto (2R,3R)-2-(3,4-dihidroxifenil)-3,4-dihidro-2H-cromen- 3,5,7-triol, que presenta la siguiente estructura:  The two enantiomers that are in cis configuration are usually referred to as epicatechin. Thus, the name epicatechin corresponds to the product (2R, 3R) -2- (3,4-dihydroxyphenyl) -3,4-dihydro-2H-chromen-3,5,7-triol, which has the following structure:

Figure imgf000011_0002
Figure imgf000011_0002

Al igual que para el isómero trans, se entiende por epicatequina el conjunto formado por los dos isómeros cis, tanto el enantiomero (2R,3R) representado arriba, como el correspondiente enantiomero (2S,3S), en el que se invierte la configuración de los dos carbonos asimétricos 2 y 3. Las catequinas también se encuentran en la naturaleza en forma de dimeros y trímeros, que se conocen por el nombre de proantocianidinas o procianidinas o proantocianidinas oligoméricas. As with the trans isomer, epicatechin is understood as the set formed by the two cis isomers, both the enantiomer (2R, 3R) represented above, and the corresponding enantiomer (2S, 3S), in which the configuration of the two asymmetric carbons 2 and 3. Catechins are also found in nature in the form of dimers and trimers, which are known by the name of proanthocyanidins or procyanidins or oligomeric proanthocyanidins.

En el marco de la presente invención se denomina catequina a cualquiera de los 4 estereoisómeros mencionados, es decir, tanto la catequina como la epicatequina y sus respectivos enantiómeros, a cualquiera de sus posibles dimeros o trímeros en la forma de proantocianidinas tipo B (dimeros formados a partir de catequina y/o epicatequina) o proantocianidinas tipo C (trímero formado a partir de epicatequina), a los dimeros en forma de galato, y a cualquier mezcla de los anteriores.  In the context of the present invention, any of the 4 stereoisomers mentioned, that is, both the catechin and the epicatechin and their respective enantiomers, is called catechin, any of its possible dimers or trimers in the form of type B proanthocyanidins (dimers formed from catechin and / or epicatechin) or proanthocyanidins type C (trimer formed from epicatechin), dimer in the form of gallate, and any mixture of the above.

Comercialmente la fuente de catequina puede ser un extracto vegetal con diferentes contenidos en catequinas, que pueden llegar a ser iguales o superiores al 90% sobre el extracto seco expresado como catequina. Por ejemplo, el extracto purificado de Vitis vinifera de la compañía Select Botanical, que se presenta en forma de un polvo anaranjado con un contenido en agua de como máximo el 8% y con un contenido de catequinas de aproximadamente el 90% sobre el extracto seco expresado como catequina, determinado por espectrofotometría, por ejemplo según se describe en el artículo Peri et al., An Assay of Different Phenolic Fractions in Wines, Am. J. Enol. Vitic., 1971 , 22(2), 55-58. Dicho extracto contiene una mezcla de trans-catequina, epicatequina, dimeros en forma de galato, y proantocianidinas. Otras fuentes de catequinas son los extractos procedentes de té verde, cacao, café verde y arándanos.  Commercially the source of catechin can be a plant extract with different contents in catechins, which can be equal to or greater than 90% on the dry extract expressed as catechin. For example, the purified extract of Vitis vinifera from the company Select Botanical, which is presented in the form of an orange powder with a water content of at most 8% and with a catechin content of approximately 90% on the dry extract expressed as catechin, determined by spectrophotometry, for example as described in the article Peri et al., An Assay of Different Phenolic Fractions in Wines, Am. J. Enol. Vitic., 1971, 22 (2), 55-58. Said extract contains a mixture of trans-catechin, epicatechin, dimer in the form of gallate, and proanthocyanidins. Other sources of catechins are extracts from green tea, cocoa, green coffee and blueberries.

Comercialmente también pueden obtenerse las formas enantioméricas puras de la catequina como, por ejemplo, (2S,3R) a través de suministradores tales como Sigma-Aldrich.  Commercially, pure enantiomeric forms of catechin can also be obtained, for example, (2S, 3R) from suppliers such as Sigma-Aldrich.

En una realización preferida de la presente invención se emplea la catequina (2S,3R)-2-(3,4-dihidroxifenil)-3,4-dihidro-2H-cromen-3,5,7-triol en forma sustancialmente pura.  In a preferred embodiment of the present invention, catechin (2S, 3R) -2- (3,4-dihydroxyphenyl) -3,4-dihydro-2H-chromen-3,5,7-triol is used in substantially pure form.

En una realización más preferida de la presente invención, la catequina es el isómero trans, en cualquiera de sus formas enantioméricas (2S,3R) ó (2R,3S), o bien una mezcla de los dos en cualquier proporción, y opcionalmente conteniendo además epicatequina en cualquiera de sus dos formas enantioméricas y/o proantocianidinas, o cualquier mezcla de los anteriores en cualquier proporción, preferentemente obtenida a partir de extractos vegetales. En una realización aún más preferida, la fuente de catequina es un extracto de uva, es decir, un extracto de Vitis vinífera preferiblemente con un contenido de catequinas igual o superior al 80% sobre el extracto seco expresado como catequina, y aún más preferiblemente se emplea un extracto purificado de Vitis vinifera con un contenido de catequinas igual o superior al 90% sobre el extracto seco expresado como catequina. In a more preferred embodiment of the present invention, the catechin is the trans isomer, in any of its enantiomeric (2S, 3R) or (2R, 3S) forms, or a mixture of the two in any proportion, and optionally further containing epicatechin in any of its two enantiomeric forms and / or proanthocyanidins, or any mixture of the above in any proportion, preferably obtained from plant extracts. In an even more preferred embodiment, the source of catechin is a grape extract, that is, an extract of Vitis vinifera preferably with a catechin content equal to or greater than 80% on the dry extract expressed as catechin, and even more preferably employs a purified extract of Vitis vinifera with a catechin content equal to or greater than 90% on the dry extract expressed as catechin.

En la presente invención se pueden emplear extractos vegetales como fuentes de los antioxidantes que contengan diferentes contenidos de resveratrol, de quercetina, de catequina, o extractos que contengan mezclas de dos o más de estos polifenoles.  In the present invention, plant extracts can be used as sources of antioxidants containing different resveratrol, quercetin, catechin, or extracts containing mixtures of two or more of these polyphenols.

Preferiblemente se emplea un extracto vegetal que contiene resveratrol sustancialmente puro, es decir, con un contenido en resveratrol superior al 90% sobre el extracto seco, preferiblemente superior al 92%, más preferiblemente superior al 95%, y aún más preferiblemente superior al 98%.  Preferably a plant extract containing substantially pure resveratrol is used, that is, with a resveratrol content greater than 90% over the dry extract, preferably greater than 92%, more preferably greater than 95%, and even more preferably greater than 98% .

Preferiblemente se emplea un extracto vegetal que contiene quercetina sustancialmente pura, es decir, con un contenido superior al 90% sobre el extracto seco, preferiblemente superior al 92%, más preferiblemente superior al 95%, y aún más preferiblemente superior al 98% expresado como dihidrato de quercetina.  Preferably a plant extract containing substantially pure quercetin is used, that is, with a content greater than 90% on the dry extract, preferably greater than 92%, more preferably greater than 95%, and even more preferably greater than 98% expressed as Quercetin dihydrate

Preferiblemente se emplea un extracto vegetal que contiene catequina sustancialmente pura, es decir, con un contenido en catequinas superior al 80% sobre el extracto seco, preferiblemente superior al 85%, y más preferiblemente superior al 90% expresado como catequina.  Preferably, a plant extract containing substantially pure catechin is used, that is, with a catechin content greater than 80% over the dry extract, preferably greater than 85%, and more preferably greater than 90% expressed as catechin.

En una realización especialmente preferida, la combinación de antioxidantes comprende resveratrol, quercetina y catequina en una relación molar resveratrol:quercetina:catequina de aproximadamente 1 :1 :2, la fuente de resveratrol es un extracto de raíz de Polygonum cuspidatum, preferiblemente con un contenido de trans-resveratrol superior al 95% sobre el extracto seco, la fuente de quercetina es un extracto de Sophora japónica, preferiblemente con un contenido de dihidrato de quercetina superior al 98% sobre el extracto seco, y la fuente de catequina es un extracto de Vitis vinífera, preferiblemente con un contenido de catequinas igual o superior al 90% sobre el extracto seco expresado como catequina. En una realización especialmente preferida, la combinación de antioxidantes comprende resveratrol, quercetina y catequina en una relación molar resveratrol:quercetina:catequina de aproximadamente 1 :1 :5, la fuente de resveratrol es un extracto de raíz de Polygonum cuspidatum, preferiblemente con un contenido de trans-resveratrol superior al 95% sobre el extracto seco, la fuente de quercetina es un extracto de Sophora japónica, preferiblemente con un contenido de dihidrato de quercetina superior al 98% sobre el extracto seco, y la fuente de catequina es un extracto de Vitis vinífera, preferiblemente con un contenido de catequinas igual o superior al 90% sobre el extracto seco expresado como catequina. In a particularly preferred embodiment, the combination of antioxidants comprises resveratrol, quercetin and catechin in a molar ratio resveratrol: quercetin: catechin of approximately 1: 1: 2, the source of resveratrol is a root extract of Polygonum cuspidatum, preferably with a content of trans-resveratrol greater than 95% on the dry extract, the source of quercetin is an extract of Sophora japan, preferably with a content of quercetin dihydrate greater than 98% on the dry extract, and the source of catechin is an extract of Vitis vinifera, preferably with a catechin content equal to or greater than 90% on the dry extract expressed as catechin. In an especially preferred embodiment, the combination of antioxidants comprises resveratrol, quercetin and catechin in a molar ratio resveratrol: quercetin: catechin of approximately 1: 1: 5, the source of resveratrol is a root extract of Polygonum cuspidatum, preferably with a content of trans-resveratrol greater than 95% on the dry extract, the source of quercetin is an extract of Sophora japan, preferably with a content of quercetin dihydrate greater than 98% on the dry extract, and the source of catechin is an extract of Vitis vinifera, preferably with a catechin content equal to or greater than 90% on the dry extract expressed as catechin.

En otra realización especialmente preferida, la combinación de antioxidantes consiste esencialmente en resveratrol, quercetina y catequina en una relación molar resveratrol:quercetina:catequina de aproximadamente 1 :1 :2, la fuente de resveratrol es un extracto de raíz de Polygonum cuspidatum, preferiblemente con un contenido de trans-resveratrol superior al 95% sobre el extracto seco, la fuente de quercetina es un extracto de Sophora japónica, preferiblemente con un contenido de dihidrato de quercetina superior al 98% sobre el extracto seco, y la fuente de catequina es un extracto de Vitis vinífera, preferiblemente con un contenido de catequinas igual o superior al 90% sobre el extracto seco, expresado como catequina.  In another especially preferred embodiment, the combination of antioxidants consists essentially of resveratrol, quercetin and catechin in a molar ratio resveratrol: quercetin: catechin of approximately 1: 1: 2, the source of resveratrol is a root extract of Polygonum cuspidatum, preferably with a content of trans-resveratrol greater than 95% on the dry extract, the source of quercetin is an extract of Sophora japan, preferably with a content of quercetin dihydrate greater than 98% on the dry extract, and the source of catechin is a Vitis vinífera extract, preferably with a catechin content equal to or greater than 90% on the dry extract, expressed as catechin.

En otra realización especialmente preferida, la combinación de antioxidantes consiste esencialmente en resveratrol, quercetina y catequina en una relación molar resveratrol:quercetina:catequina de aproximadamente 1 :1 :5, la fuente de resveratrol es un extracto de raíz de Polygonum cuspidatum, preferiblemente con un contenido de trans-resveratrol superior al 95% sobre el extracto seco, la fuente de quercetina es un extracto de Sophora japónica, preferiblemente con un contenido de dihidrato de quercetina superior al 98% sobre el extracto seco, y la fuente de catequina es un extracto de Vitis vinífera, preferiblemente con un contenido de catequinas igual o superior al 90% sobre el extracto seco expresado como catequina.  In another especially preferred embodiment, the combination of antioxidants consists essentially of resveratrol, quercetin and catechin in a molar ratio resveratrol: quercetin: catechin of approximately 1: 1: 5, the source of resveratrol is a root extract of Polygonum cuspidatum, preferably with a content of trans-resveratrol greater than 95% on the dry extract, the source of quercetin is an extract of Sophora japan, preferably with a content of quercetin dihydrate greater than 98% on the dry extract, and the source of catechin is a Vitis vinifera extract, preferably with a catechin content equal to or greater than 90% on the dry extract expressed as catechin.

En una realización preferida, la combinación de antioxidantes no contiene rutina.  In a preferred embodiment, the antioxidant combination does not contain routine.

La combinación de polifenoles que consiste en trans-resveratrol, catequina ((2R,3S)-2-(3,4-dihidroxifenil)-3,4-dihidro-2H-cromen-3,5,7-triol, su enantiómero o mezclas de ambos), epicatequina ((2R,3R)-2-(3,4-dihidroxifenil)-3,4-dihidro-2H- cromen-3,5,7-triol, su enantiómero, o mezclas de ambos), quercetina y rutina en una proporción molar 1 :1 :1 :1 :1 , en donde cada uno de los polifenoles tienen una pureza cromatográfica igual o superior al 90%, como los suministrados por la compañía Sigma-Aldrich, no forma parte de la invención. The combination of polyphenols consisting of trans-resveratrol, catechin ((2R, 3S) -2- (3,4-dihydroxyphenyl) -3,4-dihydro-2H-chromen-3,5,7-triol, its enantiomer or mixtures of both), epicatechin ((2R, 3R) -2- (3,4-dihydroxyphenyl) -3,4-dihydro-2H-chromen-3,5,7-triol, its enantiomer, or mixtures of both), Quercetin and rutin in a 1: 1: 1: 1: 1 molar ratio, where each of the polyphenols have a chromatographic purity equal to or greater than 90%, such as those supplied by the Sigma-Aldrich company, is not part of the invention.

Ensayos de poder antioxidante Antioxidant power tests

El poder antioxidante de las composiciones de la presente invención se puede determinar empleando un método in vitro diseñado para valorar la capacidad captadora de radicales libres de las sustancias ensayadas. Por ejemplo, el método denominado TOSC (del inglés Total Oxidant Scavenging Capacity), que permite la determinación del poder antioxidante de los compuestos a concentraciones bajas.  The antioxidant power of the compositions of the present invention can be determined using an in vitro method designed to assess the free radical scavenging capacity of the tested substances. For example, the method called TOSC (Total Oxidant Scavenging Capacity), which allows the determination of the antioxidant power of compounds at low concentrations.

Con el método TOSC se puede determinar el poder antioxidante de un compuesto a una concentración específica, y puede aplicarse tanto a soluciones con antioxidantes puros como en mezclas complejas.  With the TOSC method, the antioxidant power of a compound can be determined at a specific concentration, and it can be applied to both solutions with pure antioxidants and complex mixtures.

En el método TOSC se determina la capacidad de la sustancia a ensayar para inhibir la oxidación del ácido α-ceto-Y-metiltiobutírico (KMBA, del inglés alpha-keto-gamma-methylthiobutiric acid) a etileno por la acción de radicales libres como, por ejemplo, hidroxilo (HO ), peroxilo (ROO ) o peroxinitrito (ONOO"). Según se describe en Winston et al., A rapid gas chromatographic assay for determining oxyradical scavenging capacity of antioxidants and biological fluids, Free Rad. Biol. Med., 1998, 24(3), 480-493, la reacción que tiene lugar es la siguiente: In the TOSC method, the ability of the substance to be tested to inhibit the oxidation of α-keto-Y-methylthiobutyric acid (KMBA) is determined by the action of free radicals such as, for example, hydroxyl (HO), peroxyl (ROO) or peroxynitrite (ONOO " ). As described in Winston et al., A rapid gas chromatographic assay for determining oxyradical scavenging capacity of antioxidants and biological fluids, Free Rad. Biol. Med ., 1998, 24 (3), 480-493, the reaction that takes place is as follows:

H3C-S-CH2-CH2-CO-COOH ► H2C=CH2 + 1/2 (CH3-S) + C02 H 3 CS-CH 2 -CH 2 -CO-COOH ► H 2 C = CH 2 + 1/2 (CH 3 -S) + C0 2

Ubrera «¡leno Udder «leno

Preferiblemente, se realizó el ensayo TOSC frente a radicales peroxilo (ROO ) puesto que son más estables y con una vida media más larga que los radicales hidroxilo o los radicales peroxinitrito. Los radicales peroxilo pueden obtenerse por descomposición térmica e hidrólisis simétrica del compuesto 2,2'- azobis(2-metilpropionamidina) (ABAP). De este modo, el poder antioxidante de las sustancias ensayadas se puede medir por la capacidad de inhibir la formación de etileno en presencia de radicales peroxilo comparado con una reacción control, en la que no se emplea una sustancia antioxidante como inhibidor. Preferably, the TOSC test against peroxyl radicals (ROO) was performed since they are more stable and have a longer half-life than hydroxyl radicals or peroxynitrite radicals. Peroxyl radicals can be obtained by thermal decomposition and symmetric hydrolysis of the 2,2'-azobis (2-methylpropionamidine) compound (ABAP). Thus, the antioxidant power of the tested substances can be measured by the ability to inhibit the formation of ethylene in the presence of peroxyl radicals compared to a control reaction, in which an antioxidant substance is not used as an inhibitor.

Los valores TOSC se determinan según la metodología descrita en los artículos Regoli et al., Quantification of total oxidant scavenging capacity of antioxidants for peroxynitrite, peroxyl radicáis, and hydroxyl radicáis, Toxicol. Appl. Pharm., 1999, 156, 96-105 y Regoli et al., Total oxidant scavenging capacity (TOSC) of microsomal and cytosolic fractions from Antarctic, Arctic and Mediterranean scallops: differentiation between three potent oxidants, Aquat. Toxicol., 2000, 49(1-2), 13-25.  TOSC values are determined according to the methodology described in the articles Regoli et al., Quantification of total oxidant scavenging capacity of antioxidants for peroxynitrite, peroxyl radicáis, and hydroxyl radicáis, Toxicol. Appl. Pharm., 1999, 156, 96-105 and Regoli et al., Total oxidant scavenging capacity (TOSC) of microsomal and cytosolic fractions from Antarctic, Arctic and Mediterranean scallops: differentiation between three potent oxidants, Aquat. Toxicol., 2000, 49 (1-2), 13-25.

Esencialmente, los valores TOSC se cuantifican midiendo la formación de etileno, por comparación de las áreas integradas para cada sustancia ensayada y la sustancia control, según la siguiente ecuación:

Figure imgf000016_0001
Essentially, TOSC values are quantified by measuring ethylene formation, by comparison of the integrated areas for each tested substance and the control substance, according to the following equation:
Figure imgf000016_0001

Las sustancias control, sin capacidad de eliminación de radicales libres, tienen un valor TOSC del 0%, puesto que tienen la misma área bajo la curva que el control. Los compuestos que impiden completamente la formación de etileno tienen un área bajo la curva igual a 0 y, por tanto, un valor TOSC del 100%. Control substances, without the ability to eliminate free radicals, have a TOSC value of 0%, since they have the same area under the curve as the control. Compounds that completely prevent the formation of ethylene have an area under the curve equal to 0 and, therefore, a TOSC value of 100%.

Sorprendentemente, los autores de la presente invención observaron que la combinación de los polifenoles resveratrol, quercetina y catequina en las proporciones molares aproximadamente 1 :1 :2 y aproximadamente 1 :1 :5 muestran una actividad antirradicalaria sinérgica, ya que se obtienen unos valores de TOSC para las combinaciones notablemente superiores a la suma de los valores TOSC de sus componentes, tal como se describe en el Ejemplo 3.  Surprisingly, the authors of the present invention observed that the combination of the resveratrol, quercetin and catechin polyphenols in the molar proportions approximately 1: 1: 2 and approximately 1: 1: 5 show a synergistic anti-radical activity, since values of TOSC for combinations significantly greater than the sum of the TOSC values of its components, as described in Example 3.

Como resultado de este efecto sinérgico, es posible obtener un potente efecto antioxidante sin necesidad de ingerir grandes cantidades de resveratrol, o de los demás antioxidantes individuales, lo cual es ventajoso de cara a minimizar posibles riesgos de efectos secundarios.  As a result of this synergistic effect, it is possible to obtain a potent antioxidant effect without the need to ingest large amounts of resveratrol, or of the other individual antioxidants, which is advantageous in order to minimize possible risks of side effects.

Composiciones Compositions

También forma parte del objeto de la invención una composición que comprende la combinación de polifenoles de la invención y un vehículo aceptable. La composición se selecciona entre una composición farmacéutica, una composición cosmética, una composición alimenticia, un suplemento dietético, y una composición veterinaria, y el vehículo es respectivamente farmacéutica, cosmética, alimentaria, dietética, o veterinariamente aceptable. Also part of the object of the invention is a composition comprising the combination of polyphenols of the invention and an acceptable vehicle. The composition is selected from a pharmaceutical composition, a cosmetic composition, a food composition, a dietary supplement, and a veterinary composition, and the vehicle is respectively pharmaceutical, cosmetic, food, dietary, or veterinarily acceptable.

Las formas farmacéuticas aptas para incorporar la combinación de polifenoles de la presente invención pueden formularse para su administración oral, nasal, rectal, parenteral o tópica. Son adecuadas tanto las formas farmacéuticas sólidas y semi-sólidas tales como comprimidos, cremas, cápsulas duras, cápsulas blandas, grageas, presentaciones en polvo; como las líquidas o semi-líquidas, tales como jarabes o cualquier tipo de solución, suspensión o emulsión acuosa, o no acuosa.  Pharmaceutical forms suitable for incorporating the combination of polyphenols of the present invention can be formulated for oral, nasal, rectal, parenteral or topical administration. Both solid and semi-solid pharmaceutical forms such as tablets, creams, hard capsules, soft capsules, dragees, powder presentations are suitable; such as liquid or semi-liquid, such as syrups or any type of aqueous, or non-aqueous solution, suspension or emulsion.

Las composiciones farmacéuticas se formulan de acuerdo con los procedimientos que son conocidos por el experto en tecnología farmacéutica, como se describe, por ejemplo, en el libro M. E. Aulton, Farmacia. La ciencia del diseño de las formas farmacéuticas, segunda edición, Elsevier, Madrid, 2004. Por ejemplo, mediante la mezcla de la combinación antioxidante de la invención con al menos un vehículo o excipiente farmacéuticamente aceptable y, opcionalmente, con uno o más productos con funcionalidades terapéuticas o dietéticas, como por ejemplo vitaminas, minerales, oligoelementos y otros micronutrientes.  Pharmaceutical compositions are formulated according to the procedures that are known to the expert in pharmaceutical technology, as described, for example, in the book M. E. Aulton, Pharmacy. The science of the design of pharmaceutical forms, second edition, Elsevier, Madrid, 2004. For example, by mixing the antioxidant combination of the invention with at least one pharmaceutically acceptable carrier or excipient and, optionally, with one or more products with therapeutic or dietary functionalities, such as vitamins, minerals, trace elements and other micronutrients.

Los excipientes aptos para ser usados en las composiciones farmacéuticas objeto de la presente invención son bien conocidos por el experto en tecnología farmacéutica y se describen, por ejemplo, en el libro R. C. Rowe, P. J. Sheskey y P.J. Weller, Handbook of Pharmaceutical Excipients, cuarta edición, Pharmaceutical Press, 2003.  The excipients suitable for use in the pharmaceutical compositions object of the present invention are well known to the expert in pharmaceutical technology and are described, for example, in the book R. C. Rowe, P. J. Sheskey and P.J. Weller, Handbook of Pharmaceutical Excipients, fourth edition, Pharmaceutical Press, 2003.

Así por ejemplo, entre los tipos de excipientes y vehículos adecuados para ser usados en las formulaciones líquidas, en forma de soluciones, suspensiones o emulsiones, están, por ejemplo, disolventes, tampones, modificadores de la viscosidad, modificadores de la densidad, agentes tensioactivos y emulsionantes, agentes floculantes, humectantes, conservantes, edulcorantes y aromatizantes, y mezclas de los anteriores. Análogamente, entre los tipos de excipientes y/o vehículos adecuados para ser usados en las composiciones farmacéuticas sólidas están, por ejemplo, las sustancias de relleno, agentes aglutinantes, antiadherentes, lubricantes, agentes antiapelmazantes, materiales para el recubrimiento de comprimidos, gelatina para cápsulas duras y blandas, plastificantes, estabilizantes, agentes conservantes, colorantes, esencias, y sus mezclas. Thus, for example, among the types of excipients and vehicles suitable for use in liquid formulations, in the form of solutions, suspensions or emulsions, are, for example, solvents, buffers, viscosity modifiers, density modifiers, surfactants and emulsifiers, flocculating agents, humectants, preservatives, sweeteners and flavorings, and mixtures of the foregoing. Similarly, among the types of excipients and / or vehicles suitable for use in solid pharmaceutical compositions are, for example, fillers, binders, non-stick agents, lubricants, anti-caking agents, materials for the coating of tablets, gelatin for hard and soft capsules, plasticizers, stabilizers, preservatives, dyes, essences, and mixtures thereof.

La combinación de polifenoles de la invención también puede incorporarse en composiciones cosméticas para su aplicación externa, típicamente para el cuidado del cabello o de la piel. Las formas cosméticas adecuadas para incorporar las combinaciones antioxidantes de la presente invención son, por ejemplo, cremas, geles, leches, lociones, emulsiones pulverizables, y barras sólidas, entre otras.  The combination of polyphenols of the invention can also be incorporated into cosmetic compositions for external application, typically for hair or skin care. Cosmetic forms suitable for incorporating the antioxidant combinations of the present invention are, for example, creams, gels, milks, lotions, sprayable emulsions, and solid bars, among others.

Las composiciones cosméticas se formulan de acuerdo con los procedimientos que son conocidos por el experto en la materia, mediante la mezcla de la combinación de polifenoles de la invención con al menos un vehículo cosméticamente aceptable en el cual se disuelve, se emulsiona, se dispersa, o se suspende la misma. El vehículo se selecciona entre agua, un vehículo no acuoso miscible en agua, como por ejemplo etanol o isopropanol, y un vehículo no acuoso no miscible en agua, como por ejemplo aceite de parafina. Opcionalmente, las composiciones cosméticas pueden contener al menos un ingrediente cosmético adicional, que puede elegirse, por ejemplo, entre el grupo formado por agentes tensioactivos y emulsionantes, compuestos lipidíeos y emolientes, factores de consistencia y agentes espesantes, estabilizantes, hidrótropos, agentes conservantes, esencias, colorantes, compuestos de silicona, grasas, ceras, lecitinas, fosfolípidos, factores de protección solar UV, filmógenos, autobronceadores, o inhibidores de tirosina (agentes de despigmentación), o mezclas de los anteriores.  The cosmetic compositions are formulated according to the procedures that are known to the person skilled in the art, by mixing the combination of polyphenols of the invention with at least one cosmetically acceptable carrier in which it is dissolved, emulsified, dispersed, or it is suspended. The vehicle is selected from water, a water miscible non-aqueous vehicle, such as ethanol or isopropanol, and a water non-water miscible vehicle, such as paraffin oil. Optionally, the cosmetic compositions may contain at least one additional cosmetic ingredient, which may be chosen, for example, from the group consisting of surfactants and emulsifiers, lipid compounds and emollients, consistency factors and thickeners, stabilizers, hydrotropes, preservatives, essences, colorants, silicone compounds, fats, waxes, lecithins, phospholipids, UV sun protection factors, film-forming agents, self tanners, or tyrosine inhibitors (depigmentation agents), or mixtures of the above.

Así mismo, la combinación de polifenoles de la presente invención puede ser incorporada en productos alimenticios y suplementos dietéticos, por ejemplo en forma de productos nutracéuticos o alimentos funcionales o complementos alimenticios para nutrición deportiva.  Likewise, the combination of polyphenols of the present invention can be incorporated into food products and dietary supplements, for example in the form of nutraceutical products or functional foods or food supplements for sports nutrition.

La elaboración de este tipo de productos, incorporando la combinación antioxidante de la invención, se realiza mediante procedimientos conocidos por el experto en tecnología alimentaria.  The elaboration of this type of products, incorporating the antioxidant combination of the invention, is carried out by methods known to the expert in food technology.

Cualquier tipo de composición alimenticia o suplemento dietético es adecuado para incorporar la combinación de polifenoles objeto de la invención, por ejemplo, infusiones, cafés, bebidas en general tales como zumos u otras bebidas alcohólicas o no alcohólicas, productos de bollería o panadería, mermeladas, barritas energéticas, cereales, harinas, productos lácteos tales como queso, leche, mantequilla, yogures o crema, productos a base de chocolate y dulces como caramelos, gomas de mascar o helados, aceites, margarina, conservas. Any type of food composition or dietary supplement is suitable for incorporating the combination of polyphenols object of the invention, for example, infusions, coffees, drinks in general such as juices or other Alcoholic or non-alcoholic beverages, pastries or bakery products, jams, energy bars, cereals, flours, dairy products such as cheese, milk, butter, yogurts or cream, chocolate-based products and sweets such as candy, chewing gum or ice cream , oils, margarine, preserves.

Opcionalmente, el producto alimenticio que incorpora la combinación de polifenoles de la invención puede contener adicionalmente otros productos con funcionalidades terapéuticas o dietéticas, preferiblemente, vitaminas, minerales, oligoelementos u otros micronutrientes, u otros extractos vegetales fuente de polifenoles.  Optionally, the food product incorporating the combination of polyphenols of the invention may additionally contain other products with therapeutic or dietary functionalities, preferably, vitamins, minerals, trace elements or other micronutrients, or other plant extracts of polyphenols source.

Así mismo, el producto alimenticio que contiene la combinación de polifenoles de la invención, puede contener adicionalmente uno o más ingredientes, que se eligen entre los habituales aditivos alimenticios autorizados, bien conocidos por el experto en la materia, por ejemplo del tipo colorantes, conservantes, condimentos y especias, potenciadores del sabor, espesantes y gelificantes.  Likewise, the food product containing the combination of polyphenols of the invention may additionally contain one or more ingredients, which are chosen from among the usual authorized food additives, well known to those skilled in the art, for example of the type dyes, preservatives , condiments and spices, flavor enhancers, thickeners and gelling agents.

La combinación de polifenoles de la invención también puede incorporarse en composiciones veterinarias destinadas a la alimentación animal, en particular a la alimentación de animales domésticos. Dichas combinaciones se pueden incorporar a composiciones de comida para animales domésticos como, por ejemplo, las descritas en las solicitudes de patente EP-A-1514480 y WO-A- 2005/1 10037, mediante procedimientos bien conocidos por el experto en la materia. Usos  The combination of polyphenols of the invention can also be incorporated into veterinary compositions intended for animal feed, in particular for the feeding of domestic animals. Such combinations may be incorporated into pet food compositions, such as those described in patent applications EP-A-1514480 and WO-A-2005/1 10037, by methods well known to those skilled in the art. Applications

Forma parte también de la invención la utilización de la combinación para la preparación de una composición con poder antioxidante.  The use of the combination for the preparation of a composition with antioxidant power is also part of the invention.

La composición se selecciona entre el grupo formado por una composición farmacéutica, una composición cosmética, una composición alimenticia, un suplemento dietético, y una composición veterinaria.  The composition is selected from the group consisting of a pharmaceutical composition, a cosmetic composition, a food composition, a dietary supplement, and a veterinary composition.

También forma parte de la invención la combinación de la invención para uso como antioxidante.  The combination of the invention for use as an antioxidant is also part of the invention.

La combinación de polifenoles objeto de la presente invención puede ser utilizada terapéuticamente para prevenir o disminuir la progresión de todos aquellos estados patológicos susceptibles de ser tratados con sustancias antioxidantes y/o captadoras de radicales libres, como por ejemplo, cáncer, enfermedades cardiovasculares, enfermedades inflamatorias, enfermedades coronarias, diabetes, Alzheimer, esclerosis múltiple o afecciones dermatológicas tales como psoriasis o la aparición de eczemas, entre otras. The combination of polyphenols object of the present invention can be used therapeutically to prevent or decrease the progression of all those pathological conditions that can be treated with antioxidants and / or free radical scavengers, such as cancer, cardiovascular diseases, inflammatory diseases, coronary diseases, diabetes, Alzheimer's disease, multiple sclerosis or dermatological conditions such as psoriasis or the appearance of eczema , among other.

La combinación de la invención es particularmente útil para retardar los síntomas del envejecimiento, por su capacidad de proteger los órganos, tejidos y células frente a los efectos dañinos de la oxidación. También resulta apropiada, por ejemplo, para tratar el envejecimiento prematuro de la piel impidiendo la ruptura de las fibras de colágeno y, en general, de todos los tejidos.  The combination of the invention is particularly useful for delaying the symptoms of aging, for its ability to protect organs, tissues and cells against the harmful effects of oxidation. It is also appropriate, for example, to treat premature aging of the skin by preventing the breakdown of collagen fibers and, in general, all tissues.

La combinación de la invención también es particularmente adecuada para aquellos sujetos más susceptibles de generar radicales libres de forma incrementada en su organismo, por ejemplo, fumadores, personas especialmente expuestas a condiciones adversas de contaminación ambiental, radiaciones ionizantes, exceso de exposición solar, personas sujetas a situaciones de estrés, o personas que practican un ejercicio físico intenso.  The combination of the invention is also particularly suitable for those subjects most likely to generate free radicals in an increased manner in their organism, for example, smokers, people especially exposed to adverse conditions of environmental pollution, ionizing radiation, excessive sun exposure, subject people to stressful situations, or people who practice intense physical exercise.

Los ejemplos que siguen a continuación sirven para ilustrar la invención pero no deben considerarse limitantes de la misma Ejemplos  The following examples serve to illustrate the invention but should not be construed as limiting the same.

Ejemplo 1 : Preparación de una composición antioxidante de resveratrol, Example 1: Preparation of an antioxidant composition of resveratrol,

quercetina y catequina en relación molar 1 :1 :2 en base a resveratrol, quercetina y catequina procedentes de extractos vegetales  Quercetin and catechin in 1: 1: 2 molar ratio based on resveratrol, quercetin and catechin from plant extracts

En un recipiente equipado con un mezclador para productos sólidos se pesaron 253,16 g de extracto purificado de raíz de Polygonum cuspidatum con un contenido de agua del 8% y un contenido del 98% de resveratrol sobre el extracto seco, equivalente a 1 mol de resveratrol; 386,59 g de extracto purificado de Sophora japónica con un contenido de agua del 12,5% y un contenido del 100% de dihidrato de quercetina sobre el extracto seco, equivalente a 1 mol de quercetina; y 701 ,1 1 g de extracto purificado de Vitis vinífera con un contenido de agua del 8% y un contenido de catequinas del 90% sobre el extracto seco expresado como catequina, incluyendo un 12,5% de catequinas monoméricas, siendo el resto procianidinas diméricas de tipo B y triméricas de tipo C, equivalente a 2 moles de catequina, y se mezcló el conjunto hasta obtener una homogeneización completa. Ejemplo 2: Preparación de una composición antioxidante de resveratrol, In a container equipped with a mixer for solid products, 253.16 g of purified extract of Polygonum cuspidatum root were weighed with a water content of 8% and a content of 98% of resveratrol on the dry extract, equivalent to 1 mol of resveratrol; 386.59 g of purified extract of Sophora japan with a water content of 12.5% and a content of 100% quercetin dihydrate on the dry extract, equivalent to 1 mol of quercetin; and 701, 1 1 g of purified Vitis vinífera extract with a water content of 8% and a catechin content of 90% on the dry extract expressed as catechin, including 12.5% of monomeric catechins, the rest being dimeric procyanidins of type B and trimeric of type C, equivalent to 2 moles of catechin, and the whole was mixed until obtaining a complete homogenization. Example 2: Preparation of an antioxidant composition of resveratrol,

quercetina y catequina en relación molar 1 :1 :2 en base a resveratrol y quercetina procedentes de extractos vegetales y catequina (2S.3R) En un recipiente equipado con un mezclador para productos sólidos se pesaron 253,16 g de extracto purificado de raíz de Polygonum cuspidatum con un contenido de agua del 8% y un contenido del 98% de resveratrol sobre el extracto seco, equivalente a 1 mol de resveratrol; 386,59 g de extracto purificado de Sophora japónica con un contenido de agua del 12,5% y un contenido del 100% de dihidrato de quercetina sobre el extracto seco, equivalente a 1 mol de quercetina; y 580,52 g de catequina (2S,3R) sustancialmente pura (Sigma), equivalente a 2 moles de catequina, y se mezcló el conjunto hasta conseguir una homogeneización completa. Ejemplo 3: Ensayo del poder antioxidante  Quercetin and catechin in 1: 1: 2 molar ratio based on resveratrol and quercetin from vegetable extracts and catechin (2S.3R) In a container equipped with a mixer for solid products 253.16 g of purified extract of root of Polygonum cuspidatum with a water content of 8% and a 98% content of resveratrol on the dry extract, equivalent to 1 mol of resveratrol; 386.59 g of purified extract of Sophora japan with a water content of 12.5% and a content of 100% quercetin dihydrate on the dry extract, equivalent to 1 mol of quercetin; and 580.52 g of catechin (2S, 3R) substantially pure (Sigma), equivalent to 2 moles of catechin, and the whole was mixed until complete homogenization. Example 3: Antioxidant Power Test

El poder antioxidante de las composiciones de la presente invención se midió por el método TOSC, según se ha descrito anteriormente. Se utilizaron disoluciones de concentración 1 μΜ de las sustancias o mezclas a ensayar, y agua destilada como control, cuyo valor TOSC es del 0%.  The antioxidant power of the compositions of the present invention was measured by the TOSC method, as described above. Solutions of concentration 1 μ concentración of the substances or mixtures to be tested were used, and distilled water as a control, whose TOSC value is 0%.

Se prepararon las siguientes disoluciones, utilizando agua destilada como disolvente:  The following solutions were prepared, using distilled water as solvent:

1 ) Resveratrol (R): Se pesaron 253,16 mg de extracto purificado de raíz de Polygonum cuspidatum, como el empleado en el Ejemplo 1 , y se disolvieron en 1 I de agua destilada. Se tomó 1 mi de la disolución resultante y se diluyó con agua destilada hasta un volumen de 1 I. La concentración de resveratrol era 1 μΜ. 2) Quercetina (Q): Se pesaron 386,57 mg de extracto purificado de Sophora japónica, como el empleado en el Ejemplo 1 , y se disolvieron en 1 I de agua destilada. Se tomó 1 mi de la disolución resultante y se diluyó con agua destilada hasta un volumen de 1 I. La concentración de quercetina era 1 μΜ. 3) Catequina (2S.3R) (C): Se pesaron 290,26 mg de catequina (2S.3R) sustancialmente pura (Sigma) y se disolvieron en 1 I de agua destilada. Se tomó 1 mi de la disolución resultante y se diluyó con agua destilada hasta un volumen de 1 I. La concentración de catequina era 1 μΜ. 4) Catequina (Cextr): Se pesaron 350,56 mg de extracto purificado de semilla de uva Vitis vinifera, como el empleado en el Ejemplo 1 , y se disolvieron en 1 I de agua destilada. Se tomó 1 mi de la disolución resultante y se diluyó con agua destilada hasta un volumen de 1 I. La concentración de catequina era 1 μΜ. 1) Resveratrol (R): 253.16 mg of purified extract of Polygonum cuspidatum root was weighed, as used in Example 1, and dissolved in 1 I of distilled water. 1 ml of the resulting solution was taken and diluted with distilled water to a volume of 1 I. The concentration of resveratrol was 1 μΜ. 2) Quercetin (Q): 386.57 mg of purified Sophora japan extract were weighed, as used in Example 1, and dissolved in 1 I of distilled water. 1 ml of the resulting solution was taken and diluted with distilled water to a volume of 1 I. The concentration of quercetin was 1 μΜ. 3) Catechin (2S.3R) (C): 290.26 mg of substantially pure catechin (2S.3R) (Sigma) was weighed and dissolved in 1 I distilled water. 1 ml of the resulting solution was taken and diluted with distilled water to a volume of 1 I. The catechin concentration was 1 μΜ. 4) Catechin (C ex tr): 350.56 mg of purified grape seed extract Vitis vinifera was weighed, as used in Example 1, and dissolved in 1 I distilled water. 1 ml of the resulting solution was taken and diluted with distilled water to a volume of 1 I. The catechin concentration was 1 μΜ.

5) Resveratrol-quercetina-catequina R+Q+Cextr (1 :1 :2): Se tomaron 0,5 mi de la disolución R, 0,5 mi de la disolución Q y 1 mi de la disolución Cextr, y se mezclaron. Esta disolución contenía una concentración 0,25 μΜ de resveratrol, 0,25 μΜ de quercetina y 0,5 μΜ de catequina. La concentración total de polifenoles era 1 μΜ. 5) Resveratrol-quercetin-catechin R + Q + C ex tr (1: 1: 2): 0.5 ml of solution R, 0.5 ml of solution Q and 1 ml of solution C ex tr were taken , and mixed. This solution contained a concentration of 0.25 μΜ of resveratrol, 0.25 μΜ of quercetin and 0.5 μΜ of catechin. The total concentration of polyphenols was 1 μΜ.

6) Resveratrol-quercetina-catequina R+Q+Cextr (1 :1 :5): Se tomaron 0,5 mi de la disolución R, 0,5 mi de la disolución Q y 2,5 mi de la disolución Cextr, y se mezclaron. Esta disolución contenía una concentración 0,143 μΜ de resveratrol, 0,143 μΜ de quercetina y 0,714 μΜ de catequina. La concentración total de polifenoles era 1 μΜ. 6) Resveratrol-quercetin-catechin R + Q + C ex tr (1: 1: 5): 0.5 ml of solution R, 0.5 ml of solution Q and 2.5 ml of solution C were taken ex tr, and mixed. This solution contained a concentration of 0.143 μΜ of resveratrol, 0.143 μΜ of quercetin and 0.714 μΜ of catechin. The total concentration of polyphenols was 1 μΜ.

7) Resveratrol-quercetina-catequina (2S,3R) R+Q+C (1 :1 :2): Se tomaron 0,5 mi de la disolución R, 0,5 mi de la disolución Q y 1 mi de la disolución C, y se mezclaron. Esta disolución contenía una concentración 0,25 μΜ de resveratrol, 0,25 μΜ de quercetina y 0,5 μΜ de catequina. La concentración total de polifenoles era 1 μΜ. 8) Resveratrol-quercetina-catequina (2S,3R) R+Q+C (1 :1 :5): Se tomaron 0,5 mi de la disolución R, 0,5 mi de la disolución Q y 2,5 mi de la disolución C, y se mezclaron. Esta disolución contenía una concentración 0,143 μΜ de resveratrol, 0,143 μΜ de quercetina y 0,714 μΜ de catequina. La concentración total de polifenoles era 1 μΜ. 7) Resveratrol-quercetin-catechin (2S, 3R) R + Q + C (1: 1: 2): 0.5 ml of solution R, 0.5 ml of solution Q and 1 ml of solution were taken C, and mixed. This solution contained a concentration of 0.25 μΜ of resveratrol, 0.25 μΜ of quercetin and 0.5 μΜ of catechin. The total concentration of polyphenols was 1 μΜ. 8) Resveratrol-quercetin-catechin (2S, 3R) R + Q + C (1: 1: 5): 0.5 ml of solution R, 0.5 ml of solution Q and 2.5 ml of solution were taken solution C, and mixed. This solution contained a concentration of 0.143 μΜ of resveratrol, 0.143 μΜ of quercetin and 0.714 μΜ of catechin. The total concentration of polyphenols was 1 μΜ.

La formación de etileno durante el ensayo TOSC se monitorizó mediante cromatografía de gases, con un equipo HP 5890-series II, Software HP Chemstation 5890, y se calculó mediante la determinación del área bajo la curva, mediante el programa SRI PeakSimple®. La regresión lineal se calculó usando el programa GraphPad Prism®. La pendiente de la regresión se calculó en el margen lineal de la curva control TOSC frente a la concentración de los activos ensayados. Ethylene formation during the TOSC test was monitored by gas chromatography, with HP 5890-series II equipment, HP Chemstation 5890 Software, and calculated by determining the area under the curve, using the SRI PeakSimple ® program . Linear regression was calculated using the GraphPad Prism ® program . The slope of the regression was calculated in the linear margin of the TOSC control curve versus the concentration of the assets tested.

Se obtuvieron los resultados que se muestran en la Tabla I. The results shown in Table I were obtained.

TABLA I TABLE I

Figure imgf000023_0001
Figure imgf000023_0001

La columna "TOSC calculado" representa el valor TOSC que corresponde teóricamente a las muestras de las diferentes combinaciones de antioxidantes teniendo en cuenta solamente un efecto aditivo de cada uno de ellos. Así pues, el valor calculado se obtiene multiplicando la concentración de cada uno de los antioxidantes en la muestra por el TOSC experimental de cada uno de los antioxidantes individuales y dividiendo por la concentración del antioxidante en la muestra individual. Por ejemplo en el caso de la muestra 5: The column "TOSC calculated" represents the TOSC value that theoretically corresponds to the samples of the different combinations of antioxidants taking into account only an additive effect of each of them. Thus, the calculated value is obtained by multiplying the concentration of each of the antioxidants in the sample by the experimental TOSC of each of the individual antioxidants and dividing by the concentration of the antioxidant in the individual sample. For example in the case of sample 5:

TOSC calculado = (0,25 μΜ R x 22,00/1 μΜ) + (0,25 μΜ Q x 1 1 ,00/1 μΜ) + + (0,5 μΜ C x 8,00/1 μΜ) = 12,25 %  TOSC calculated = (0.25 μΜ R x 22.00 / 1 μΜ) + (0.25 μΜ Q x 1 1.00 / 1 μΜ) + + (0.5 μΜ C x 8.00 / 1 μΜ) = 12.25%

La columna "Incremento" corresponde a la diferencia entre el valor TOSC calculado y el experimental, y permite cuantificar el efecto sinérgico observado en el poder antioxidante de las combinaciones. Puede observarse que la combinación de resveratrol, quercetina y catequina de la invención, tanto en la relación molar 1 :1 :2, como en la relación molar 1 :1 :5, muestra un notable efecto sinérgico. Así mismo, puede observarse que, aunque el efecto sinérgico con catequina (2S,3R) pura es ligeramente superior al de la catequina procedente de extracto de uva, se aprecia en ambos casos un efecto sinérgico comparable, independiente, pues, de la fuente de catequinas empleada.  The "Increment" column corresponds to the difference between the calculated and experimental TOSC value, and allows quantifying the synergistic effect observed in the antioxidant power of the combinations. It can be seen that the combination of resveratrol, quercetin and catechin of the invention, both in the 1: 1: 2 molar ratio, and in the 1: 1: 5 molar ratio, shows a remarkable synergistic effect. Likewise, it can be observed that, although the synergistic effect with pure catechin (2S, 3R) is slightly higher than that of catechin from grape extract, a comparable synergistic effect can be appreciated in both cases, independent of the source of Catechins used.

La columna "Potencia" refleja el número de veces que aumenta el poder antioxidante con las combinaciones objeto de la invención en comparación con el poder antioxidante que se obtiene a partir de la adición por separado de los poderes antioxidantes de resveratrol, quercetina y catequina.  The "Potency" column reflects the number of times the antioxidant power increases with the combinations object of the invention compared to the antioxidant power obtained from the separate addition of the antioxidant powers of resveratrol, quercetin and catechin.

Ejemplo 4: Preparación de un complemento alimenticio para la prevención del envejecimiento cutáneo Example 4: Preparation of a food supplement for the prevention of skin aging

Se prepararon cápsulas de gelatina blanda (8/10 oval) de color rojo con el siguiente relleno por cápsula: Soft gelatin capsules (8/10 oval) of red color were prepared with the following filling per capsule:

Componente Cantidad Component Quantity

(mg)  (mg)

Extracto purificado de raíz de Polygonum cuspidatum del Ejemplo 1 33,53 Purified extract of Polygonum cuspidatum root from Example 1 33.53

Extracto purificado de Sophora japónica del Ejemplo 1 52,18 Purified extract of Japan Sophora from Example 1 52,18

Extracto purificado de semilla de uva del Ejemplo 1 94,65 Purified grape seed extract of Example 1 94.65

Acetato de D,L-a-tocoferol 10,00 D acetate, L-a-tocopherol 10.00

Aceite de borraja (> 20% ácido γ-linoleico) 150,00 Borage oil (> 20% γ-linoleic acid) 150.00

Grasa de soja hidrogenada 10,00 Cera de abejas 5,00 Hydrogenated soybean fat 10.00 Beeswax 5.00

La relación molar resveratrol:quercetina:catequina en este preparado es 1 :1 :2,04. Ejemplo 5: Preparación de un complemento alimenticio para la mejora de la prevención de la degeneración macular asociada a la edad The molar ratio resveratrol: quercetin: catechin in this preparation is 1: 1: 2.04. Example 5: Preparation of a food supplement for the improvement of the prevention of age-related macular degeneration

Se prepararon cápsulas de gelatina blanda (14/16 oblongo) de color negro con el siguiente relleno por cápsula: Soft gelatin capsules (14/16 oblong) of black color were prepared with the following filling per capsule:

Figure imgf000025_0001
Figure imgf000025_0001

La relación molar resveratrol:quercetina:catequina en este preparado es de 1 :0,97:1 ,98. Ejemplo 6: Preparación de un complemento alimenticio para reparación de las arrugas de expresión Se prepararon sobres con el siguiente relleno por sobre: The molar ratio resveratrol: quercetin: catechin in this preparation is 1: 0.97: 1, 98. Example 6: Preparation of a food supplement for repair of expression wrinkles Envelopes were prepared with the following filling per envelope:

Figure imgf000026_0001
Figure imgf000026_0001

La relación molar resveratrol:quercetina:catequina en este preparadoThe molar ratio resveratrol: quercetin: catechin in this preparation

1 :1 :2. 1: 1: 2.

Ejemplo 7: Preparación de un alimento funcional a base de café para la prevención de la enfermedad cardiovascular Example 7: Preparation of a functional coffee-based food for the prevention of cardiovascular disease

Se prepararon sobres monodosis con el siguiente relleno por sobre: Componente Cantidad Single-dose sachets were prepared with the following filling per envelope: Component Quantity

Café descafeinado 30,00 g Decaffeinated coffee 30.00 g

Extracto purificado de raíz de Polygonum cuspidatum del Ejemplo 1 37,61 mg Purified extract of Polygonum cuspidatum root from Example 1 37.61 mg

Extracto purificado de Sophora japónica del Ejemplo 1 58,62 mg Purified extract of Japan Sophora from Example 1 58.62 mg

Extracto purificado de semilla de uva del Ejemplo 1 261 ,16 mg Purified grape seed extract of Example 1 261, 16 mg

Aroma de moka 50,00 mg Aroma of moka 50.00 mg

Ácido cítrico 100,00 mg Citric acid 100.00 mg

La relación molar resveratrol:quercetina:catequina en este preparado esThe molar ratio resveratrol: quercetin: catechin in this preparation is

1 :1 :5. 1: 1: 5.

Ejemplo 8: Preparación de un complemento alimenticio a base de sustancias naturales como antioxidante en nutrición deportiva Example 8: Preparation of a food supplement based on natural substances as an antioxidant in sports nutrition

Se prepararon cápsulas blandas de gelatina blanda (20 oblongo) de color morado con el siguiente relleno por cápsula: Soft gelatin soft capsules (20 oblong) of purple color were prepared with the following filling per capsule:

Componente Cantidad Component Quantity

(mg)  (mg)

Coenzima Q10 100,00 Coenzyme Q10 100.00

Extracto purificado de raíz de Polygonum cuspidatum del Ejemplo 1 37,61 Purified Polygonum cuspidatum root extract of Example 1 37.61

Extracto purificado de Sophora japónica del Ejemplo 1 58,62 Purified extract of Japan Sophora from Example 1 58.62

Extracto purificado de semilla de uva del Ejemplo 1 261 ,16 Purified grape seed extract of Example 1 261, 16

RRR-alfa-tocoferol (67%) 15,00 RRR-alpha-tocopherol (67%) 15.00

Vitamina C 60,00 Vitamin C 60.00

Beta-caroteno dunaliella (95% retinol) 30,00 Beta-carotene dunaliella (95% retinol) 30.00

Aceite de germen de trigo 500,00 Grasa de soja hidrogenada 20,00 Wheat Germ Oil 500.00 Hydrogenated soybean fat 20.00

Cera de abejas 10,00 Beeswax 10.00

La relación molar resveratrol:quercetina:catequina en este preparado esThe molar ratio resveratrol: quercetin: catechin in this preparation is

1 :1 :5. 1: 1: 5.

Ejemplo 9: Preparación de un suplemento alimenticio para la mejora del aspecto de la piel y brillo del pelaje en mascotas (mamíferos) Example 9: Preparation of a nutritional supplement for the improvement of the appearance of the skin and brightness of the fur in pets (mammals)

Se prepararon cápsulas de gelatina blanda (18/20 oblongo) de color rojo con el siguiente relleno por cápsula: Soft gelatin capsules (18/20 oblong) of red color were prepared with the following filling per capsule:

Figure imgf000028_0001
Figure imgf000028_0001

La relación molar resveratrol:quercetina:catequina en este preparado es 1 :1 :5,09. The molar ratio resveratrol: quercetin: catechin in this preparation is 1: 1: 5.09.

Ejemplo 10: Preparación de un suplemento alimenticio para la mejora de la fertilidad de sementales (mamíferos) Se prepararon cápsulas de gelatina blanda (22 oblongo) de color rojo con el siguiente relleno por cápsula: Example 10: Preparation of a nutritional supplement to improve the fertility of stallions (mammals) Soft gelatin capsules (22 oblong) of red color were prepared with the following filling per capsule:

Figure imgf000029_0001
Figure imgf000029_0001

La relación molar resveratrol:quercetina:catequina en este preparado esThe molar ratio resveratrol: quercetin: catechin in this preparation is

1 :1 :5. 1: 1: 5.

Claims

R E I V I N D I C A C I O N E S 1. - Combinación sinérgica de polifenoles que comprende resveratrol, quercetina y catequina, caracterizada porque la relación molar entre resveratrol, quercetina y catequina es 0,9-1 ,1 :0, 9-1 ,1 :1 ,8-2,2 ó 0,9-1 ,1 :0, 9-1 ,1 :4, 5-5, 5, con la condición de que la combinación de polifenoles que consiste en trans-resveratrol, catequina, epicatequina, quercetina y rutina en una proporción molar 1 :1 :1 :1 :1 , en donde cada uno de los polifenoles tienen una pureza cromatográfica igual o superior al 90% se excluye expresamente. 1. - Synergistic combination of polyphenols comprising resveratrol, quercetin and catechin, characterized in that the molar ratio between resveratrol, quercetin and catechin is 0.9-1, 1: 0, 9-1, 1: 1, 8-2.2 or 0.9-1, 1: 0, 9-1, 1: 4, 5-5, 5, with the proviso that the combination of polyphenols consisting of trans-resveratrol, catechin, epicatechin, quercetin and routine in one 1: 1: 1: 1: 1 molar ratio, where each of the polyphenols have a chromatographic purity equal to or greater than 90% is expressly excluded. 2. - Combinación según la reivindicación 1 , caracterizada porque la relación molar es 1 :1 :2 ó 1 :1 :5. 2. - Combination according to claim 1, characterized in that the molar ratio is 1: 1: 2 or 1: 1: 5. 3. - Combinación según la reivindicación 2, caracterizada porque la relación molar es 1 :1 :2. 3. - Combination according to claim 2, characterized in that the molar ratio is 1: 1: 2. 4. - Combinación según la reivindicación 2, caracterizada porque la relación molar es 1 :1 :5. 4. - Combination according to claim 2, characterized in that the molar ratio is 1: 1: 5. 5.- Combinación según una cualquiera de las reivindicaciones 1 a 4, caracterizada porque el resveratrol es trans-resveratrol. 5. Combination according to any one of claims 1 to 4, characterized in that the resveratrol is trans-resveratrol. 6. - Combinación según una cualquiera de las reivindicaciones 1 a 5, caracterizada porque el resveratrol es de origen natural. 6. - Combination according to any one of claims 1 to 5, characterized in that the resveratrol is of natural origin. 7. - Combinación según la reivindicación 6, caracterizado porque la fuente de resveratrol es un extracto vegetal. 7. - Combination according to claim 6, characterized in that the source of resveratrol is a plant extract. 8. - Combinación según la reivindicación 7, caracterizada porque el extracto vegetal es un extracto de raíz de Polygonum cuspidatum. 8. - Combination according to claim 7, characterized in that the plant extract is a root extract of Polygonum cuspidatum. 9. - Combinación según una cualquiera de las reivindicaciones 1 a 8, caracterizada porque la quercetina es de origen natural. 9. - Combination according to any one of claims 1 to 8, characterized in that the quercetin is of natural origin. 10. - Combinación según la reivindicación 9, caracterizada porque la fuente de quercetina es un extracto vegetal. 10. - Combination according to claim 9, characterized in that the source of quercetin is a plant extract. 1 1 . - Combinación según la reivindicación 10, caracterizada porque el extracto vegetal es un extracto de Sophora japónica. eleven . - Combination according to claim 10, characterized in that the plant extract is an extract of Sophora Japan. 12. - Combinación según una cualquiera de las reivindicaciones 1 a 1 1 , caracterizada porque la fuente de catequina es un extracto vegetal. 12. - Combination according to any one of claims 1 to 1 1, characterized in that the source of catechin is a plant extract. 13.- Combinación según la reivindicación 12, caracterizada porque el extracto vegetal es un extracto de Vitis vinífera. 13. Combination according to claim 12, characterized in that the plant extract is an extract of Vitis vinífera. 14. - Combinación según la reivindicación 1 , caracterizada porque la relación molar resveratrol:quercetina:catequina es 0,9-1 ,1 :0,9-1 ,1 :1 ,8-2,2, la fuente de resveratrol es un extracto de raíz de Polygonum cuspidatum, la fuente de quercetina es un extracto de Sophora japónica, y la fuente de catequina es un extracto de Vitis vinífera. 14. - Combination according to claim 1, characterized in that the resveratrol: quercetin: catechin molar ratio is 0.9-1, 1: 0.9-1, 1: 1, 8-2.2, the source of resveratrol is a Polygonum cuspidatum root extract, the source of quercetin is an extract of Sophora japan, and the source of catechin is an extract of Vitis vinifera. 15. - Combinación según la reivindicación 1 , caracterizada porque la relación molar resveratrol:quercetina:catequina es 0,9-1 ,1 :0,9-1 ,1 :4,5-5,5, la fuente de resveratrol es un extracto de raíz de Polygonum cuspidatum, la fuente de quercetina es un extracto de Sophora japónica, y la fuente de catequina es un extracto de Vitis vinífera. 15. - Combination according to claim 1, characterized in that the resveratrol: quercetin: catechin molar ratio is 0.9-1, 1: 0.9-1, 1: 4.5-5.5, the source of resveratrol is a Polygonum cuspidatum root extract, the source of quercetin is an extract of Sophora japan, and the source of catechin is an extract of Vitis vinifera. 16.- Composición que comprende la combinación según una cualquiera de las reivindicaciones 1 a 15 y un vehículo aceptable. 16. Composition comprising the combination according to any one of claims 1 to 15 and an acceptable vehicle. 17. - Composición según la reivindicación 16, caracterizada porque la composición es farmacéutica y el vehículo es farmacéuticamente aceptable. 17. - Composition according to claim 16, characterized in that the composition is pharmaceutical and the vehicle is pharmaceutically acceptable. 18. - Composición según la reivindicación 16, caracterizada porque la composición es cosmética y el vehículo es cosméticamente aceptable. 18. - Composition according to claim 16, characterized in that the composition is cosmetic and the vehicle is cosmetically acceptable. 19.- Composición según la reivindicación 16, caracterizada porque la composición es un suplemento dietético y el vehículo es dietéticamente aceptable. 19. Composition according to claim 16, characterized in that the composition is a dietary supplement and the vehicle is dietically acceptable. 20.- Composición según la reivindicación 16, caracterizada porque la composición es alimentaria y el vehículo es alimentariamente aceptable. 20. Composition according to claim 16, characterized in that the composition is food and the vehicle is food acceptable. 21 . - Composición según la reivindicación 16, caracterizada porque la composición es veterinaria y el vehículo es veterinariamente aceptable. twenty-one . - Composition according to claim 16, characterized in that the composition is veterinary and the vehicle is veterinarily acceptable. 22. - Utilización de la combinación según una cualquiera de las reivindicaciones 1 a 15 para la preparación de una composición con poder antioxidante. 22. - Use of the combination according to any one of claims 1 to 15 for the preparation of a composition with antioxidant power. 23.- Combinación según una cualquiera de las reivindicaciones 1 a 15 para uso como antioxidante. 23. Combination according to any one of claims 1 to 15 for use as an antioxidant.
PCT/ES2012/070302 2011-05-04 2012-05-02 Synergic polyphenol combination Ceased WO2012150370A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ESP201130710 2011-05-04
ES201130710A ES2391211B1 (en) 2011-05-04 2011-05-04 SYNERGIC POLYPHENOL COMBINATION

Publications (1)

Publication Number Publication Date
WO2012150370A1 true WO2012150370A1 (en) 2012-11-08

Family

ID=46317421

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES2012/070302 Ceased WO2012150370A1 (en) 2011-05-04 2012-05-02 Synergic polyphenol combination

Country Status (2)

Country Link
ES (1) ES2391211B1 (en)
WO (1) WO2012150370A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20130397A1 (en) * 2013-03-15 2014-09-16 Giuliani Spa FLAVONID BASED COMPOSITION FOR PHARMACEUTICAL, NUTRITIONAL OR COSMETIC USE WITH ENHANCED ANTIOXIDANT ACTION
WO2015134688A1 (en) 2014-03-07 2015-09-11 Dow Global Technologies Llc Nitrone compounds and their use in personal care
WO2016003767A1 (en) 2014-06-30 2016-01-07 Dow Global Technologies Llc Polymeric nitrones and their use in personal care
US9730874B2 (en) 2014-05-12 2017-08-15 Dow Global Technologies Llc Nitrone compounds and their use in personal care
US10130574B2 (en) 2015-03-20 2018-11-20 Dow Global Technologies Llc Nitrone inhibition of oxidation of unsaturated fats
US10137071B2 (en) 2015-03-20 2018-11-27 Dow Global Technologies Llc Nitrone inhibition of oxidation of unsaturated fats
CN109982694A (en) * 2016-09-27 2019-07-05 株式会社爱茉莉太平洋 Catechin absorption enhancer that enhances catechin absorption in small intestinal epithelial cells
EP3074028B1 (en) * 2013-11-27 2022-04-06 Research Foundation Of The City University Of New York Activity enhancing curcumin compositions and methods of use

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002034262A1 (en) * 2000-10-25 2002-05-02 Giuliani S.P.A. Combination of catechin and quercetin for pharmaceutical or dietary use
WO2002081651A2 (en) 2001-02-20 2002-10-17 Uab Research Foundation Polyphenolics for enhancing endothelial cell-mediated fibrinolysis
WO2003015738A1 (en) 2001-08-18 2003-02-27 Cognis Iberia, S.L. Active ingredient mixtures
ES2217966A1 (en) 2003-03-24 2004-11-01 Leonardo Jorda Quiles Set of food products based on chaff extract consists of high antioxidant blends also containing black grape seeds and stalks
WO2005004630A1 (en) * 2003-07-09 2005-01-20 Giuliani S.P.A. Composition with antioxidant activity for pharmaceutical or dietary or cosmetic use
EP1514480A1 (en) 2003-09-05 2005-03-16 Kao Corporation Pet food
WO2005110037A2 (en) 2004-05-10 2005-11-24 The Iams Company Pet food compositions
US20100247670A1 (en) 2009-03-26 2010-09-30 Dmitriy Shoutov Red Grape Dry Composition and Health Tea
WO2010135589A2 (en) 2009-05-20 2010-11-25 Sakura Properties, Llc Dietary supplement drink for delivery of resveratrol and other polyphenols

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102266440B (en) * 2006-10-24 2015-06-17 戴维·W·克雷姆平 Antiresorptive and osteogenic dietary supplement and method of use
US20080254135A1 (en) * 2007-04-10 2008-10-16 Marvin Heuer Resveratrol-containing compositions for general health and vitality

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002034262A1 (en) * 2000-10-25 2002-05-02 Giuliani S.P.A. Combination of catechin and quercetin for pharmaceutical or dietary use
WO2002081651A2 (en) 2001-02-20 2002-10-17 Uab Research Foundation Polyphenolics for enhancing endothelial cell-mediated fibrinolysis
WO2003015738A1 (en) 2001-08-18 2003-02-27 Cognis Iberia, S.L. Active ingredient mixtures
ES2217966A1 (en) 2003-03-24 2004-11-01 Leonardo Jorda Quiles Set of food products based on chaff extract consists of high antioxidant blends also containing black grape seeds and stalks
WO2005004630A1 (en) * 2003-07-09 2005-01-20 Giuliani S.P.A. Composition with antioxidant activity for pharmaceutical or dietary or cosmetic use
EP1514480A1 (en) 2003-09-05 2005-03-16 Kao Corporation Pet food
WO2005110037A2 (en) 2004-05-10 2005-11-24 The Iams Company Pet food compositions
US20100247670A1 (en) 2009-03-26 2010-09-30 Dmitriy Shoutov Red Grape Dry Composition and Health Tea
WO2010135589A2 (en) 2009-05-20 2010-11-25 Sakura Properties, Llc Dietary supplement drink for delivery of resveratrol and other polyphenols

Non-Patent Citations (17)

* Cited by examiner, † Cited by third party
Title
BAUR ET AL.: "Resveratrol improves health and survival of mice on a high-calorie diet", NATURE, vol. 444, 2006, pages 337 - 342, XP002634406, DOI: doi:10.1038/NATURE05354
BEECHER ET AL.: "Analysis of tea polyphenols", PROC. SOC. EXP. BIOL. MED., vol. 220, no. 4, 1999, pages 267 - 70
DE SANTI ET AL.: "Sulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoids", XENOBIOTICA, vol. 30, no. 9, 2000, pages 857 - 866
FARINA ET AL.: "An improved synthesis of resveratrol", NAT. PROD. RES., vol. 20, no. 3, 2006, pages 247 - 52, XP008149060, DOI: doi:10.1080/14786410500059532
KOLOUCHOVD-HANZLFKOV6 ET AL.: "Rapid method for resveratrol determination by HPLC with electrochemical and UV detections in wines", FOOD CHEM., vol. 87, no. 1, 2004, pages 151 - 158
M. E. AULTON: "Farmacia. La ciencia del diseno de las formas farmacéuticas", 2004, ELSEVIER
M. J. TAKAOKA: "Of the phenolic substances of white hellebore (Veratrum grandiflorum Loes. fil", vol. 3, 1949, J. FACULTY SCI. HOKKAIDO IMPERIAL UNIVERSITY, pages: 1 - 16
PERI ET AL.: "An Assay of Different Phenolic Fractions in Wines", AM. J. ENOL. VITIC., vol. 22, no. 2, 1971, pages 55 - 58
PLUMB ET AL., ANTIOXIDANT PROPERTIES OF CATECHINS AND PROANTHOCYANIDINS: EFFECT OF POLYMERISATION, GALLOYLATION AND GLYCOSYLATION, vol. 29, no. 4, 1998, pages 351 - 8
R. C. ROWE; P. J. SHESKEY; P.J. WELLER: "Handbook of Pharmaceutical Excipients", 2003, PHARMACEUTICAL PRESS
REGOLI ET AL.: "Quantification of total oxidant scavenging capacity of antioxidants for peroxynitrite, peroxyl radicals, and hydroxyl radicals", TOXICOL. APPL. PHARM., vol. 156, 1999, pages 96 - 105
REGOLI ET AL.: "Total oxidant scavenging capacity (TOSC) of microsomal and cytosolic fractions from Antarctic, Arctic and Mediterranean scallops: differentiation between three potent oxidants", AQUAT. TOXICOL., vol. 49, no. 1-2, 2000, pages 13 - 25
SHAKHOVA ET AL., ZH. OBSHCH. KHIM., vol. 32, 1962, pages 390
SIEMANN ET AL.: "Concentration of the phytoalexin resveratrol in wine", AM. J. ENO. VITIC., FREE. RAD. RES., vol. 43, 1992, pages 49 - 52, XP008099992
WALLE ET AL.: "High absorption but very low bioavailability of oral resveratrol in humans", DRUG METAB. DISP., vol. 32, no. 12, 2004, pages 1377 - 1382
WINSTON ET AL.: "A rapid gas chromatographic assay for determining oxyradical scavenging capacity of antioxidants and biological fluids", FREE RAD. BIOL. MED., vol. 24, no. 3, 1998, pages 480 - 493, XP008092749, DOI: doi:10.1016/S0891-5849(97)00277-3
ZHANG ET AL.: "Antioxidant properties of quercetin", ADV. EXP. MED. BIOL., vol. 915, 2011, pages 283 - 9

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20130397A1 (en) * 2013-03-15 2014-09-16 Giuliani Spa FLAVONID BASED COMPOSITION FOR PHARMACEUTICAL, NUTRITIONAL OR COSMETIC USE WITH ENHANCED ANTIOXIDANT ACTION
EP3074028B1 (en) * 2013-11-27 2022-04-06 Research Foundation Of The City University Of New York Activity enhancing curcumin compositions and methods of use
US9828335B2 (en) 2014-03-07 2017-11-28 Dow Global Technologies Llc Nitrone compounds and their use in personal care
US9701625B2 (en) 2014-03-07 2017-07-11 Dow Global Technologies Llc Nitrone compounds and their use in personal care
WO2015134688A1 (en) 2014-03-07 2015-09-11 Dow Global Technologies Llc Nitrone compounds and their use in personal care
US9730874B2 (en) 2014-05-12 2017-08-15 Dow Global Technologies Llc Nitrone compounds and their use in personal care
US9796667B2 (en) 2014-05-12 2017-10-24 Dow Global Technologies Llc Nitrone compounds and their use in personal care
WO2016003767A1 (en) 2014-06-30 2016-01-07 Dow Global Technologies Llc Polymeric nitrones and their use in personal care
US10064804B2 (en) 2014-06-30 2018-09-04 Dow Global Technologies Llc Polymeric nitrones and their use in personal care
US10130574B2 (en) 2015-03-20 2018-11-20 Dow Global Technologies Llc Nitrone inhibition of oxidation of unsaturated fats
US10137071B2 (en) 2015-03-20 2018-11-27 Dow Global Technologies Llc Nitrone inhibition of oxidation of unsaturated fats
CN109982694A (en) * 2016-09-27 2019-07-05 株式会社爱茉莉太平洋 Catechin absorption enhancer that enhances catechin absorption in small intestinal epithelial cells
US20190223486A1 (en) * 2016-09-27 2019-07-25 Amorepacific Corporation Catechin absorption enhancer for enhancing catechin absorption in small intestinal epithelial cells

Also Published As

Publication number Publication date
ES2391211A1 (en) 2012-11-22
ES2391211B1 (en) 2013-10-02

Similar Documents

Publication Publication Date Title
ES2391211B1 (en) SYNERGIC POLYPHENOL COMBINATION
ES2606663T3 (en) Compositions containing cis isomers of carotenoids and corresponding method
US9180077B2 (en) Green tea extracts of improved bioavailability
US20080254135A1 (en) Resveratrol-containing compositions for general health and vitality
ES2683296T3 (en) Flavonoid-based composition for pharmaceutical, nutritional or cosmetic use with enhanced antioxidant action
US20170080040A1 (en) Decoction of olive leaves
TWI523611B (en) Antioxidant dietary supplement compositions
ES2720628T3 (en) Grape extract, nutritional supplement that includes it and its use as a functional ingredient
ES2426314T3 (en) Combination of proanthocyanidins such as picnogenol or grape seeds and Asian sparkle for the treatment of cardiovascular disorders such as atherosclerosis
Taeymans et al. 55 use of food supplements as nutricosmetics in health and fitness
Rehman et al. Bioactive compounds and biological activities of red beetroot (Beta vulgaris L.)
ES2217966B1 (en) FOOD PRODUCTS THAT INCLUDE AN EXTRACT OF HOLLEJO, SEEDS AND GRAPE SCRATCHES.
ES2445492B1 (en) Antioxidant compositions of a product obtained from the fruit of camu camu
JP6045164B2 (en) Composition comprising long-life herb polyphenols and vitamin E and / or vitamin C
CA2585010A1 (en) Resveratrol-containing compositions for general health and vitality
JP2015096498A (en) AGEs decomposer
ES3020236T3 (en) Superfood for prolonging the longevity of an individual
JP4139969B2 (en) Fading inhibitor
KR101661423B1 (en) anti-oxidant and anti-inflammation composition extracted from Isodon excisus, and its extracting method
ES2231031B1 (en) FOOD PRODUCTS AND COMPOSITIONS THAT INCLUDE AN EXTRACT OF TUBERIFIED ROOTS OF BLACK CARROT CARROT- (DAUCUS CAROTA L. -APIACEAE-) VALUED IN ANTIOXIDANT INTERNATIONAL UNITS.
Wang et al. A comprehensive review of Prinsepia utilis Royle used for food, medicine and cosmetics
Soraya et al. Formulation of Nutraceutical Jelly Candy from a Combination of Cucurbita moschata Puree and Averrhoa carambola Juice as Antioxidant
KR20170025350A (en) Composition for improving skin
Shegog Characterization of perseoranjin, a natural orange pigment from avocado (Persea americana) seed, and its uses as a natural food colorant
Romero et al. Bioactive Compounds of Tropical Fruits as Health Promoters

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12727890

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12727890

Country of ref document: EP

Kind code of ref document: A1